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ARTICLE
Distinct regulation of hippocampal neuroplasticity
and ciliary genes by corticosteroid receptors
Karen R. Mifsud 1, Clare L. M. Kennedy1, Silvia Salatino2, Eshita Sharma 2, Emily M. Price 1,
Samantha N. Haque1, Andriana Gialeli3, Hannah M. Goss 1, Polina E. Panchenko 1, John Broxholme2,
Simon Engledow 2, Helen Lockstone2, Oscar Cordero Llana 3 & Johannes M. H. M. Reul 1✉
Glucocorticoid hormones (GCs) — acting through hippocampal mineralocorticoid receptors
(MRs) and glucocorticoid receptors (GRs) — are critical to physiological regulation and
behavioural adaptation. We conducted genome-wide MR and GR ChIP-seq and Ribo-Zero
RNA-seq studies on rat hippocampus to elucidate MR- and GR-regulated genes under cir-
cadian variation or acute stress. In a subset of genes, these physiological conditions resulted
in enhanced MR and/or GR binding to DNA sequences and associated transcriptional
changes. Binding of MR at a substantial number of sites however remained unchanged. MR
and GR binding occur at overlapping as well as distinct loci. Moreover, although the GC
response element (GRE) was the predominant motif, the transcription factor recognition site
composition within MR and GR binding peaks show marked differences. Pathway analysis
uncovered that MR and GR regulate a substantial number of genes involved in synaptic/
neuro-plasticity, cell morphology and development, behavior, and neuropsychiatric disorders.
We find that MR, not GR, is the predominant receptor binding to >50 ciliary genes; and that
MR function is linked to neuronal differentiation and ciliogenesis in human fetal neuronal
progenitor cells. These results show that hippocampal MRs and GRs constitutively and
dynamically regulate genomic activities underpinning neuronal plasticity and behavioral
adaptation to changing environments.
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G lucocorticoid hormones (GCs) are of critical importancefor central nervous system functioning both during dailyactivities and after a stressful challenge. They play a
pivotal role in stress resilience and behavioral adaptation1–5.
Impaired GC secretion and function has been associated with
stress-related mental disorders like major depression and post-
traumatic stress disorder3,5,6.
GC secretion from the adrenal glands varies over the circadian
cycle, peaking at the onset of the active phase. Exposure to a
stressful event results in a transient surge of GC secretion that is
superimposed on the circadian variation. In the brain, GCs bind
to two types of receptors, the mineralocorticoid receptor (MR)
and the glucocorticoid receptor (GR)7, which show striking dif-
ferences in localization and function in the brain. Whilst
expression of MR is predominantly in neurons within specific
limbic structures such as the hippocampus and lateral septum,
GR is widely distributed throughout the brain, including the
hippocampus8. MRs and GRs co-localize in hippocampal
neurons8,9. Once bound and activated by GCs, MRs and GRs
translocate to the cell nucleus to act as ligand-dependent tran-
scription factors. It is thought that genomic actions in the hip-
pocampus underlie the distinct roles of MR and GR in the control
of circadian and stress-related physiology, cognition and beha-
viour, however, the molecular underpinnings of these receptor-
mediated actions are still largely unresolved10,11.
Comprehensive knowledge about genome-wide MR and GR
interactions within the hippocampus under physiological condi-
tions is currently lacking. Specifically, which genes are regulated
by MR and/or GR after stress or across the circadian cycle is still
unknown. Previously, we conducted chromatin immunoprecipi-
tation (ChIP) analyses to assess the binding of MR and GR to
well-known GC-target genes in the hippocampus of rats killed
under baseline and stress conditions12. This study showed for the
first time that MRs and GRs bind to GC-response elements
(GREs) within the GC-target genes Fkbp5 (FK506 binding protein
5), Per1 (Period circadian regulator 1) and Sgk1 (serum/gluco-
corticoid regulated kinase 1) as homo- or heterodimers in a gene-
and GRE-dependent manner in vivo12. Despite providing novel
insight into the complexity of MR/GR interaction, the conclu-
sions of this study were limited to those genes. Therefore, a
comprehensive genome-wide study into GC receptor interaction
with the DNA was required to identify MR- and GR-regulated
genes and clarify the possible existence of selectively MR- or GR-
regulated genes. Moreover, as long as the identity of all MR- and
GR-targeted genes is undetermined, the full implications of GC
signaling in the hippocampus will be unknown.
Therefore, in this study, we investigated the interaction of MR
and GR with the entire genome of the rat hippocampus after an
acute stress exposure (forced swimming (FS)) as well as under
baseline early morning (BLAM) and baseline late afternoon
(BLPM) conditions. Moreover, we integrated these data with
genome-wide gene transcriptional responses occurring in the rat
hippocampus under the same conditions. This approach revealed
a comprehensive map of the genomic loci bound by MR and/or
GR, the transcription factor binding motifs involved, as well as
the associated gene transcriptional responses providing novel
insights into the function of MR and GR in the hippocampus.
Results
MR and GR ChIP-seq reveals overlapping and distinct features
in genome regulation in the hippocampus. Genome-wide
changes in hippocampal MR and GR binding after acute stress,
or in response to the circadian rise in corticosterone levels, were
quantified by ChIP followed by next-generation sequencing
(ChIP-seq). MR and GR ChIP-seq was performed on
hippocampal chromatin samples (n= 4 independent samples per
group) from rats killed under baseline conditions (BLAM,
7.00–9.00 am; BLPM, 5.30–7.00 pm, representing the trough and
peak of circadian GC secretion, respectively), or 30 min after the
start of an acute, 15-min FS challenge, i.e. at the peak of the
stress-evoked plasma corticosterone rise (FS30; Supplementary
Fig. 1a). Regions of the genome with significant peaks of MR or
GR binding over input were identified (Supplementary Data 1 &
2) and summarized in Fig. 1. Under BLAM conditions, MRs
bound to >300 sites on average across all samples which increased
significantly following acute stress (>5-fold, p < 0.05) or at the
circadian peak (>7-fold, p < 0.005) (Fig. 1a). In contrast, GRs
bound to <100 sites on average under BLAM conditions but this
number increased ∼20-fold (p < 0.0001) following acute stress.
The circadian peak resulted in GR binding at over 750 sites on
average, representing an >8-fold increase (p < 0.005) compared
with BLAM GR binding levels (Fig. 1a). On top of each bar,
Fig. 1a also provides the number of unique genes showing an MR
or GR peak in any of the 4 replicates. Binding of MR and GR to
well-characterized target genes, such as Fkbp5, Per1, and Sgk1,
was consistent with our previously reported findings (Supple-
mentary Data 1 and 2)12. A representative image of MR and GR
binding peaks within intron 5 of Fkbp5 is provided in Fig. 1b. MR
and GR are clearly binding to the same region within this intron
and therefore this location constitutes an overlapping MR/GR
peak, which is consistent with previously observed MR-GR
coincident binding (as revealed by tandem ChIP) at this genomic
site12. To determine to which extent MR and GR were binding to
the same or distinct loci in each data set (BLAM, FS30, BLPM),
Venn diagrams were created to show the number of selective vs.
overlapping peaks for each experimental condition. To ensure
maximal stringency, these data only included peaks which
exclusively bound one receptor in all four replicates but not the
other receptor in any replicate (‘selective peaks’, Fig. 1c–e)’ or
those that bound both receptors in all four replicates per condi-
tion (‘overlapping peaks’, Fig. 1c-e, Supplementary Data 3).
Interestingly, the number of selective MR peaks was substantially
higher than that of selective GR peaks under all experimental
conditions (BLAM: 55 MR peaks vs 0 GR peaks; FS30: 107 MR
peaks vs. 61 GR peaks; BLPM: 356 MR peaks vs. 3 GR peaks).
Analysis of the genomic location of MR and GR binding peaks
from all samples (Supplementary Data 1 & 2) revealed the highest
levels of binding within distal intergenic regions (MR, 40–50% of
peaks; GR, 50–70% of peaks, depending on the experimental
condition) (MR, Fig. 1f; GR, Fig. 1g). The remaining peaks were
predominantly located in the promoter or intronic regions. Acute
stress and circadian influences led to significant increases in the
percentage of both MR and GR peaks within intronic regions and
a corresponding relative reduction in the percentage of peaks at
promoter (MR) or intergenic regions (GR), representing a change
in the relative distribution of peaks due to the experimental
condition (Fig. 1f, g). Supplementary Figure 2 provides an
overview of the distribution of MR and GR peaks across all
chromosomes for each of the four independent replicates and all
physiological conditions studied. These peak distribution over-
views confirm the increase in MR and GR peaks in the BLPM and
FS30 replicates compared with BLAM samples. The increases in
MR and GR peaks occur across all chromosomes, including the
X-chromosome but not the Y-chromosome where only one peak
was found in only a few samples under any condition.
The top-500 peaks, based on statistical significance (false
discovery rate, FDR), from the MR and GR datasets were
subjected to de novo motif analysis using the Multiple
Expectation maximization for Motif Elicitation (MEME)
software13 to identify the binding motif with the highest
occurrence and statistical significance. As expected, with high
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statistical significance, the most prevalent motif was matched to a
palindromic GRE (Nr3c1, Nr3c2 and AR motifs) for both MR
(Fig. 1h; E= 1.2e−157) and GR (Fig. 1i; E= 8.7e−688) binding
datasets. Whilst a GRE was present in 100% of the top-500 most
significant GR peaks, only ∼67% of the top-500 most significant
MR peaks contained a GRE, prompting the question about other
non-GRE MR binding motifs (addressed later in this paper).
Genome-wide MR and GR binding is regulated by acute stress
and circadian influences. To determine the effect of acute stress
and circadian influences on the genome-wide binding of MR and
GR, the FS30 and BLPM data were compared with the BLAM
data through differential binding analysis, which was performed
with the R package DiffBind. This analysis identified genomic
regions in which MR binding and GR binding was significantly
(FDR ≤ 0.05) upregulated or downregulated in the FS30 or BLPM
conditions when compared with the BLAM condition. A corre-
lation heat map of the read count data shows a robust clustering
of biological replicate samples obtained under each of the three
experimental conditions, as well as showing a clear differentiation
between samples collected under BLAM or BLPM conditions, or
after stress for both MR (Fig. 2a) and GR (Fig. 2b). DiffBind first
used MACS2-called MR or GR peaks to derive a consensus peak
set for each transcription factor (MR or GR). A total of 1753 MR
peaks and 1066 GR peaks were subsequently analyzed by the
DiffBind algorithm and annotated to the nearest gene (1505 genes
for MR; 932 genes for GR) using the Bedtools suite. We found
that the majority of MR and GR peaks responded to both acute
MR GR MR GR     MR GR
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stress and the BLPM condition (FDR≤0.05; Supplementary
Data 4). Volcano plots depicting the direction of change versus
the statistical significance level show that almost all differentially
regulated peaks were upregulated after acute stress (MR, Fig. 2c;
GR, Fig. 2d) and in response to the circadian drive (CIRC; MR,
Fig. 2e; GR, Fig. 2f). This analysis also found that a substantial
number of MR peaks did not respond to stress or circadian
changes (Fig. 2c, e), whereas this was less the case for GR peaks
(Fig. 2d, f). Furthermore, follow-up analyses showed that most of
the non-responsive MR peaks (i.e. 490 peaks, 28% of all MR
peaks) did not respond to either stress or circadian changes
(Fig. 2g). We termed these peaks as being constant. Similarly, we
assessed that 59 GR peaks (5.5% of all GR peaks) are constant,
thus not responding to either physiological change (Fig. 2h). The
constant MR and GR peaks including their gene annotations are
listed in Supplementary Data 4 (‘CON’ tabs).
Together, these findings indicate that the interaction of GR
with the genome in response to stress and circadian changes is
dynamic and corresponds with this receptor’s differential GC
occupancy pattern under these physiological conditions versus
the BLAM situation7. Regarding MR, the situation is more
complex. Most MR interactions with the genome respond
dynamically to stress and circadian changes, which is in line
with our previous findings regarding a few classic GC target
genes12. At the same time, more than a quarter of genomic MR
binding is constant. The latter observation dovetails with the
long-standing notion that MRs play a key role in mediating
constitutive (‘tonic’14) effects of GCs. Clearly, however, MRs have
a dynamic role as well.
MR and GR peaks encompass distinct patterns of transcription
factor binding motifs. We showed that MEME analysis on the
top-500 MR and GR peaks had identified the GRE consensus
sequence as the predominant transcription factor binding motif
(see Fig. 1h and i). To investigate the presence of such motifs in
all 1753 MR and 1066 GR binding peaks included in the DiffBind
analysis (Supplementary Data 4), the Find Individual Motif
Occurrences (FIMO) software was used (Supplementary Data 5).
This motif analysis indeed revealed the presence of GREs in 93%
of GR peaks (Supplementary Table 1). It also showed that 68-74%
of these peaks encompass Krüppel-like Factor (KLF; 68%), Spe-
cificity Protein (SP; 70%) and Zinc Finger (ZNF; 74%) motifs. In
the MR peaks, a relatively lower incidence of GREs (77%) was
observed (Supplementary Table 1). Moreover, we found that the
incidence of other motifs such as early growth response protein
(EGR; 64%), KLF (70%), SP (74%) and ZNF (76%) was almost
similar. These observations support the notion that MRs and
GRs, in addition to interacting with GREs, may also interact with
other motifs and/or interact with other transcription factors at
other motifs.
The high incidence of non-GRE binding motifs for MR
prompts the question: if MR or GR peaks do not contain a
consensus GRE motif, which would be the predominant binding
motifs present in such cases? Among the total of 1753 MR and
1066 GR peaks we found 401 MR peaks and 74 GR peaks that did
not encompass a GRE motif. FIMO analysis identified SP (80%),
KLF (78%), ZNF (76%), EGR (74%) and RFX (Regulatory Factor
X; 73%) as the predominant motifs within the non-GRE-
containing MR peaks. With the exception of RFX, these are also
amongst the most prominently present motifs if all MR peaks
were considered indicating that MRs may interact with such
motifs in the presence or absence of a GRE. Within the non-GRE-
containing GR peaks, the most frequently observed motifs were
Nuclear Receptor (NR; 65%) and Signal Transducer and
Activator of Transcription (STAT; 62%). Interestingly, these
motifs were not present among the top-5 motifs after FIMO
analysis on all GR peaks.
Hippocampal gene transcription changes after acute stress and
circadian variation. RNA extracted from the hippocampi of rats
killed under baseline conditions (BLAM or BLPM) or at various
time points after acute FS stress was sequenced following ribo-
somal RNA (rRNA) depletion (Ribo-Zero RNA-seq). Supple-
mentary Figure 1b shows the plasma corticosterone responses in
these rats which mirror levels obtained in animals used to gen-
erate ChIP-Seq samples. After quality control steps and bioin-
formatics analyses, count tables for both intronic and exonic
sequence reads were generated (Supplementary Data 6 and 7,
respectively). The majority of intronic reads could be attributed to
the nuclear RNA pool and, as such, are a good representation of
the heteronuclear RNA (hnRNA) content15. hnRNA comprises
the unspliced, direct transcript from a gene, therefore its levels
provide a more direct index of gene transcriptional activity than
the (spliced) mRNA levels, which are a composite measure of
RNA synthesis and breakdown. Exonic reads include count data
from both mRNA and hnRNA species regardless of poly-
adenylation status, which is an advantage over the more tradi-
tional poly-A+ selection approach15. To investigate the effects of
acute stress and circadian changes on gene transcription,
expression levels at each time point after stress and in the BLPM
group were compared with levels at BLAM using differential
Fig. 1 Identification of significant MR and GR binding peaks within the rat hippocampus. Genomic regions significantly bound by MR and GR under early
baseline conditions (BLAM), 30min following forced swimming (FS30), or under late baseline conditions (BLPM) were identified. a The average number of
significant MR and GR peaks [± SEM, n= 4 biologically independent samples] under BLAM (MR = 345, GR = 86), FS30 (MR = 1849, GR = 1660) and
BLPM (MR = 2610, GR = 767) conditions. Above each bar, we depicted the number of unique genes within 5 kb of a peak occurring in any of the four
replicates. One-way ANOVA: MR: F(2,9)= 10.06, p= 0.0051; GR: F(2,9)= 59.01, p < 0.0001; *p < 0.05 compared with the respective BLAM group, post-
hoc Dunnett’s multiple comparison test. b Representative images of significant MR and GR peaks within intron 5 of Fkbp5 (FK506 binding protein 5) at
BLAM, FS30 and BLPM. Images representative of 4 biologically independent samples. c–e Venn diagrams representing the number of selective (no cross-
reactivity with opposite receptor in any samples) and overlapping MR and GR peaks at each time point and present in all four biologically independent
samples (c BLAM; d FS30; e BLPM). We performed a Fisher’s exact test for each Venn diagram and found all overlaps to be highly significant: p= 1.0874e
−24 for the BLAM condition and P= 0 for the FS30 and BLPM conditions (zero indicating a value too small to be reported). f, g Genomic location of all MR
and GR peaks at each time point represented as % of peaks intersected from all 4 biologically independent samples (Mean ± SEM (n= 4), Two-way
ANOVA; f (MR): Effect of condition (BLAM, FS30, BLPM): F(2, 81)= 1.786e−007, p > 0.9999; Effect of genomic location: F(8, 81)= 561.7, p < 0.001;
Interaction: F(16, 81)= 18.05, p < 0.001; *P≤ 0.006, post-hoc Dunnett’s test; g (GR): Effect of condition (BLAM, FS30, BLPM): F(2, 81)= 4.720e−006,
p > 0.9999; Effect of genomic location: F(8, 81)= 1436, p < 0.001; Interaction: F(16, 81)= 45.49, p < 0.001; *p < 0.01, post-hoc Dunnett’s test. Source data
are provided in the Source Data File. h, i The motif with the highest occurrence and statistical significance (E values) as identified by de novo motif analysis
(h, MR; I, GR). This search was carried out within the top-500 MR and GR peaks on the basis of FDR values across all experimental conditions. The
identified motif matched that of the glucocorticoid response element (GRE) for both receptors.
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Fig. 2 Differential binding of MR and GR after acute stress or during the circadian rise as compared with early morning baseline (BLAM) conditions.
Differential binding (DiffBind) analysis determined whether the binding of MRs and GRs was significantly up- or down-regulated following acute stress
(FS30) or circadian changes (BLPM) compared with BLAM conditions. a, b Correlation heat maps represent read count data of biological replicates
subjected to DiffBind analysis (a MR ChIP; b GR ChIP). c–f Scatterplots display the fold-change in binding (log2 FC) of MR and GR versus the statistical
significance of the change (-log10FDR) following acute stress (FS30 vs BLAM: c MR; d GR) or during circadian changes (BLPM vs BLAM: e MR; f GR).
Stress-responsive (STRESS) and circadian-responsive (CIRC) peaks are shown as red circles and green circles, respectively. Blue circles depict
nonresponsive (NON-RES) peaks. The number of peaks are given between brackets. Pie charts showing the proportion of MR peaks (g) and GR peaks (h)
significantly responding to either stress or circadian influences (Responsive), or peaks in which receptor binding remained unchanged to both conditions
(Constant). Source data are provided in the Source Data File.
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expression analysis (EdgeR) (Supplementary Data 8 (intronic
reads), Supplementary Data 9 (exonic reads)).
To assess experiment quality, we conducted principal compo-
nent analysis (PCA) using the 1000 most variable genes based on
the analysis of the intronic and exonic read counts. Figure 3a–c
show the PCA analysis on the intronic data of the BLPM and the
FS30 and FS60 time points compared with the BLAM intronic
data. In each comparison, the experimental groups separate along
PC1 indicating consistent transcriptional changes within groups.
PCA of all comparisons including the FS120-, FS180- and FS360-
BLAM comparisons are shown in Supplementary Fig. 3. While
PCA on intron counts showed strong separation between
experimental groups, PCA on the exonic read data only revealed
clustering in the BLPM- and, to some extent, the FS30-BLAM
comparisons (Supplementary Fig. 4). This further affirms our
hypothesis that intronic reads reflect a more direct measure of
transcriptional activity at the measured time points. Using the top
50 differentially expressed genes from each comparison (BLPM,
FS30, FS60 vs. BLAM) we obtained a further view on the
transcriptional response in these conditions (Fig. 3d). These top
differentially expressed genes present a clear distinction between
the respective experimental groups and the BLAM group. We can
observe the overall similarity between the FS60 and BLPM groups
(top segment), a more distinctive BLPM signal (second from the
top), genes with high expression at FS30 (second from bottom),
as well as genes with high expression at BLAM that decreases in
Fig. 3 RNA-Seq data analysis of rat hippocampal samples. Samples were collected under BLAM, 30 or 60min following forced swimming (FS30 or FS60,
respectively), or under BLPM conditions. a-c Principal component analysis (PCA) of the top 1000 most variable genes based on intronic read counts
revealed clear separation of experimental groups along the PC1 axis indicating much of the variance (~35%) associated with this eigenvector can be
attributed to group for BLPM vs BLAM (a), FS30 vs BLAM (b) and FS60 vs BLAM (c) comparisons. d Heatmap showing centered log-scaled expression
values in each sample for the top 104 differentially expressed genes (FDR < 0.05). Top 50 differentially expressed genes were identified, using intronic
count data, in each comparison (FS30, FS60, and BLPM vs. BLAM conditions) and collated to a single list of 104 genes.
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other conditions (bottom segment). Fkbp5, Fgf2 (Fibroblast
Growth Factor 2), Zbtb16 (Zinc Finger and BTB Domain
Containing 16), Glul (Glutamate-Ammonia Ligase) and Hif3a
(Hypoxia Inducible Factor 3a) are some key genes that showed an
increased expression both after stress and in BLPM (Fig. 3d).
Interestingly, one of the top differentially expressed genes with
significantly decreased expression at FS60 is Nr3c1 (which
encodes GR); an observation corresponding with our earlier
findings16.
To compare inRNA expression with exRNA expression across
physiological conditions, we compiled the stress time-course data
and the BLPM data and present them as constant (CON) RNA
levels and responsive (RES) RNA levels to either physiological
condition (Fig. 4a, b). Stress- and circadian-induced changes in
the RNA expression of individual genes can be found in
Supplementary Data 8 and 9. Furthermore, we determined the
maximal fold change in intronic and exonic reads (regardless of
time point and direction) in response to acute stress for each
gene along with its FDR values. These stress-responsive genes
were collated and labelled as ‘FS merged table’ in Supplementary
Data 8 and 9. As presented for both intronic (Fig. 4a) and exonic
data (Fig. 4b), most genes expressed in the hippocampus showed
constant (CON) expression, i.e. no significant change in
expression across all physiological conditions (FDR > 0.05;
Fig. 4a, b; excluding low expressed genes with less than 10 reads
mapped to each sample in the group). We found, however, >4-
times more responsive (RES) genes showing significant changes
(FDR < 0.05) in intronic (cf. exonic) RNA expression (Fig. 4a, b).
This difference between differentially expressed genes identified
using intronic vs. exonic reads is also illustrated in the volcano
plots (Fig. 4c, d; number of genes: intronic reads: 1979; exonic
reads: 549).
Figure 4e and f show a direct comparison of the magnitude of
the stress-induced versus circadian drive-associated changes
identified using intronic and exonic read quantification. This
comparison was conducted on those RNAs with changes after
both stress and circadian variation. The analysis revealed
significant positive (Spearman) correlations for both intronic
(rs(470)= 0.9281, p < 0.0001; Fig. 4e) and exonic (rs(171)=
0.8909, p < 0.0001; Fig. 4f) genes, indicating a shared regulatory
mechanism for stress and circadian variation. Interestingly, a few
genes showed opposing responses to acute stress and the
circadian drive (Triangles, Fig. 4e and f) indicating that these
genes are likely to be regulated by different mechanisms under
these distinct physiological states.
Integration of ChIP-seq and RNA-seq data reveals correlations
between MR and GR binding and the magnitude of the gene
transcriptional response. Subsequently, we addressed the ques-
tion: to what extent is MR or GR binding to genes under the
different physiological conditions linked to the respective RNA
response of such genes in the hippocampus? We found that, of
the 1505 MR-binding genes and the 932 GR-binding genes used
in the DiffBind analysis (Supplementary Data 4), the expression
of 1198 (∼80%) and 718 (∼77%) genes, respectively, could be
detected based on intronic and/or exonic RNA count data
(Supplementary Data 10). Next, we asked whether these genes
would bind both MR and GR, only MR, or only GR. 48% of the
genes (i.e. 662 genes) showed MR binding (MR-only), ∼39% (536
genes) both MR and GR binding, and ∼13% (182 genes) GR
binding (GR-only). To further scrutinize the specificity of these
genes in terms of exclusive MR or GR binding across all four
independent replicates, we examined the binding data from
individual samples. Of the 662 genes designated as MR-only, 366
were exclusively associated with MR binding, whilst only 28 of the
182 designated as GR-only were exclusively associated with GR
binding, i.e. no evidence of opposite receptor binding in any of
the individual samples (Supplementary Data 10). Thus, of all
RNA expressing, MR/GR binding genes across all three physio-
logical conditions, 366 genes exclusively bind MR (no GR in any
sample), 28 genes bind exclusively GR (no MR binding in any
sample), and 536 genes bind both MR and GR in all replicate
samples.
Subsequently, we determined whether changes in MR and/or
GR binding, occurring after stress or during the circadian rise,
were correlated with the transcriptional RNA responses in the
respective gene. We performed correlation analysis on those
genes that showed both a significant change in MR or GR
binding in either physiological condition and a significant
change in gene expression (in terms of inRNA or exRNA) in
these physiological conditions. We found significant, positive
correlations between the fold-change in MR binding and the
changes in associated inRNA after stress (Fig. 5a) and during
the circadian drive (Fig. 5b). Furthermore, a significant, positive
correlation was found between changes in GR binding and
inRNA during the circadian rise (Fig. 5d) but not after stress
(Fig. 5c). Regarding correlations between exRNA changes and
changes in MR or GR binding, we only found significant
correlations between MR and GR versus exRNA changes as a
result of the circadian rise, but not after stress (Supplementary
Fig. 5).
Pathway analysis of MR and/or GR bound genes shows indi-
vidual and overlapping roles for these receptors in the hippo-
campus. Regarding pathway analysis, we initially used the Gene
Ontology (GO) pathway analysis on all RNA-expressing genes
with associated MR-only binding (n= 366, Fig. 6a), MR and
GR binding (536 genes, Fig. 6b) or GR-only binding (n= 28
genes) (Supplementary Data 11). Given the low number of
RNA-expressing GR-only genes, this analysis did not result in
any significant pathway associations. In contrast, GO pathway
analysis generated an association of MR-only binding with 59
genes involved in cilium structure and function (Fig. 6a; Sup-
plementary Data 11). Strikingly, most (>70%) of these genes
showed constant MR binding across all conditions. In a high
proportion (>90%) of these (42) constant genes, MR was
binding to genomic regions without a GRE motif but with RFX
motifs present (38) (Supplementary Data 11). Such cilium-
related genes included those encoding transition zone/ciliary
gate proteins (e.g. Tmem17, B9d2), centrosomal proteins (e.g.
Cep41, Prkar1a), intraflagellar transport proteins (e.g. Ift43,
Ift57, Ift122), axonemal dyneins (e.g. Dnah2, Dync2h1) as well
as cilia and flagella associated proteins (Cfap; i.e. Cfap20,
Cfap298).
An association of both MR and GR was found with genes
involved in the post-synapse structure and neuronal/dendritic
spine morphology and function (Fig. 6b). Examples of such
synaptic plasticity-related genes include calmodulin-dependent
protein kinase genes (Camk1d, Camk2a), glutamate receptor
genes (Gria1, Gria2, Grik4, Grin2a), post-synaptic density-
associated genes (e.g. Ptk2b, Dlgap1, Magi2), and spine
morphology-associated genes (Capzb, Map1b). A complete list
of GO-generated ‘cellular components’ enriched genes can be
found in Supplementary Data 11.
In addition to GO enrichment analysis, we used the Ingenuity
Pathway Analysis (IPA) suite to analyze both the FS30 and BLPM
MR and GR ChIP-Seq data sets, initially, at FDR≤1, thus
including all MR and GR bound genes. IPA confirmed the
selective association of MR with genes encoding cilia-related
structures and (dys)functions (Fig. 6c, d). As expected, due to the
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constant nature of the majority of these cilia-related genes, the
FS30 and BLPM data showed very similar results.
Subsequently, we conducted IPA analysis on the MR- and GR-
bound genes, which showed significant differential binding (FDR
< 0.1) under FS30 and BLPM conditions (Fig. 7). Figure 7
presents various categories grouping a substantial number of
genes involved in cell morphology, cell-to-cell signalling, and cell
development and movement, as well as genes associated with
behavior and neuropsychiatric diseases. Significant associations of


































Fig. 4 Differential expression analysis of hippocampal RNA. Differential expression analysis was conducted on intronic RNA (inRNA; a, c, e) and exonic
RNA (exRNA; b, d, f) under different physiological conditions compared with BLAM conditions. Differential expression (edgeR) analysis identified genes of
which the intronic or exonic expression was upregulated or downregulated (referred to as responsive (RES)) or remained stable (constant (CON))
following acute stress or the circadian rise. a, b Pie charts displaying the proportion of genes of which the intronic (a) and exonic (b) RNA expression is
significantly altered in response to stress or circadian influences (RES) or genes of which the expression does not change between conditions (CON). c, d
Volcano plots showing the fold-change in RNA expression (log2 FC) versus the statistical significance of the change (-log10 FDR). RES genes are shown in
red circles whereas CON genes are depicted in blue circles. c Intronic RNA, d exonic RNA). e, f Scatter plots displaying the highly significant Spearman rank
correlations between changes in gene expression following stress (FS) and those under circadian influences (BLPM). Intronic (e); n= 470, rs= 0.9295, p <
0.0001; Exonic (f); n= 171, rs = 0.8198, p < 0.0001. Genes responding in the same direction to both stress and the circadian drive are depicted by red
circles, whilst genes showed opposing responses to acute stress and the circadian drive are depicted by red triangles (e, Intronic RNA; f, exonic RNA).
Source data are provided in the Source Data File.
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processes like neurito- and dendritogenesis, inter-neuronal
communication like synaptic transmission including long-term
potentiation (LTP) and long-term depression (LTD), and
neuronal developmental and migratory processes (Fig. 7). In
terms of behavior, MR- and GR-associated genes were found to
be particularly involved in learning and memory, as well as
anxiety-related behaviors. Corresponding with hippocampus
function, spatial learning and memory was highlighted. In many
categories, a high (>2) Z Score was found indicating a significant
activation of these cellular and cognitive functions. IPA also
revealed associations of MR- and GR-bound genes with mental,
cognitive and neurodegenerative disorders. In view of the
significant negative Z Score, it appears that MR-associated
genes exert an inhibitory action on neurodegenerative processes
(Fig. 7). The analysis of MR- and GR-associated genes revealed
involvement in largely parallel functional pathways with the
exception of neuronal differentiation, spatial learning, and
neurodegeneration. There was considerable similarity between
the outcome of the pathway analyses conducted on MR- and GR-
associated genes in the FS30 versus the BLPM condition. This
observation was supported by the high degree of similarity (86.5-
100%) in receptor-associated genes between these physiological
conditions as determined by Jaccard analysis (Supplementary
Data 12).
Supplementary Data 12 also shows the top-15 canonical
pathways linked to MR- and GR-associated genes as analyzed
within IPA based on p value and Z score (>2 or <-2). Comparison
of MR- and GR-associated pathways presents a substantial level
of overlap, but differences as well. For instance, the synaptic LTP
and LTD pathways, calcium signalling, Wnt/Ca2+ (although non-
canonical), CREB signalling, and the TEC kinase signalling
pathway could be found among both MR-bound and GR-bound
data bases of both FS30 and BLPM conditions (Supplementary
Data 12). In contrast, AMPK signalling, Rac signalling, and ERK/
MAPK signalling were among the top-15 of MR-bound genes, but
not so for the GR-bound genes. Conversely, GR-associated
canonical pathway analysis featured micropinocytosis, Sphingo-
sine-1-phosphate, IL-6, and ErbB4 signalling which could not be
found among the top-15 list of MR-associated pathway analysis
(Supplementary Data 12). Nevertheless, based on this analysis,
MR and GR clearly bind to genes participating in inter-neuronal
communication (LTP, LTD), neuroplasticity (e.g. nNOS, calcium,
CREB, ERK/MAPK, Wnt/Ca2+, integrin signalling), cellular
metabolism (AMPK signalling), as well as differentiation, growth,
migration and survival mechanisms (e.g. TEC, Rac, phospholi-
pase C, sphingosine-1-phosphate signalling). This canonical
pathway analysis revealed a number of pathways showing a high



































Fig. 5 Spearman rank correlation analysis between the fold-change in receptor binding and the associated fold-change in RNA expression under stress
and circadian conditions. The results of the correlation analysis are depicted in the subfigures. A significant positive correlation was found between the
fold-change in MR binding and the fold-change in inRNA levels after exposure to acute stress (a) and during the circadian rise (b). The change in GR
binding post-stress did not significantly correlate with the change in inRNA levels (c). The increased GR binding and the changes in inRNA levels as a result
of the circadian rise, however, showed a significant positive correlation (d). Source data are provided in the Source Data File.
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indicating an activated status. The overlap between the BLPM
and FS30 databases was particularly striking for the pathway
analysis of the GR ChIP data: the top-15 list was identical with
almost identical p values and Z-scores (Supplementary Data 12).
This result suggests that GCs via GR engage the same signalling
pathways irrespective of whether GC secretion was brought about
by acute stress or the circadian drive.
In Fig. 8, we highlight two typical cilium-related genes and two
typical neuroplasticity genes from the MR/GR ChIP-seq and
RNA-seq data sets. Their gene maps are shown in Supplementary
Fig. 6. The chosen two cilium MR-selective genes are centrosomal
protein 41 (Cep41)17 and intraflagellar transport 57 (Ift57)18
(Fig. 8a–c). The gene promoter of Cep41 showed constant
binding by MR in all 12 samples across all three physiological
conditions and there was no significant GR binding to this region
in any of the samples. Likewise, we found constant MR binding in
the gene promoter of Ift57 in 10 out of 12 samples across
conditions with no significant binding of GR in any samples. As
illustrated in Fig. 8a–c, neither acute stress nor the circadian drive
induced a significant change in MR binding in either gene
(Fig. 8a) and expression of both intronic and exonic Cep41 and
Ift57 RNA was stable under all experimental conditions (Fig. 8b,
c).
Protein-tyrosine kinase 2-beta (Ptk2b)19 and Camk2a20 are
neuroplasticity-related genes that both contain multiple MR and
GR binding sites (Supplementary Fig. 6). Acute stress and BLPM
conditions both resulted in significantly increased MR and GR
binding to both Ptk2b and Camk2a GREs (Fig. 8d). The increase
in MR and GR binding to Ptk2b was associated with increased
intronic RNA expression following stress and during BLPM
conditions (Fig. 8e). Regarding Camk2a, however, only stress but
not BLPM conditions resulted in a significant increase in intronic
RNA expression compared with BLAM levels (Fig. 8e). No
changes in Ptk2b and Camk2a exRNA counts were found under
these conditions (Fig. 8f).
Experimental replication in a distinct cohort of rats validates
findings from ChIP-seq and RNA-seq experiments. To further
validate the findings from the ChIP-seq and RNA-seq experi-
ments described above, a similar experimental design was applied
to an independent cohort of rats with the addition of an extra
experimental group which exposed rats to FS at the PM time
period. These rats were either killed at 30 min (for ChIP analysis
—FS30(PM)) or 60 min (for RNA analysis—FS60(PM)) after the
start of stress. Circulating corticosterone levels in BLAM, FS30
and BLPM rats of this experiment were very similar to those in
the original sequencing experiments (Supplementary Fig. 1a–d).
Animals that were exposed to FS in the PM showed augmented
corticosterone peak levels (at FS30(PM); Supplementary Fig. 1c),
most likely due to enhanced HPA drive at this time of day, but
relatively lower hormone levels at 60 min post-stress (FS60(PM))
compared with BLPM levels (Supplementary Fig. 1d). The latter
finding can be explained by the increased feedback of stress-
induced corticosterone at this time of day.
MR and GR ChIP-qPCR analysis of Ptk2b, Camk2a, Ift57 and
Cep41 on hippocampus tissue of BLAM, FS30 and BLPM
groups of this cohort confirmed our findings in the ChIP-Seq
study (Supplementary Fig. 7). We also included Hif3a in this
analysis as one of the highest responding genes in terms of both
MR and GR binding and RNA expression. We found
significantly increased binding of MR and GR at Ptk2b,
Fig. 6 Pathway analysis reveals distinct and common cellular components associated with genes binding MRs and GRs and showing RNA expression.
a, b Bar charts showing the top significantly enriched GO cellular component terms (-log10 FDR) identified for MR-only (n= 339, a) or both MR-and-GR-
(n= 496, b) bound RNA-expressing genes. There were not enough GR-only bound genes expressing RNA (n= 28) to produce a significant output. GO
cellular components associated with MR-only binding were predominantly cilia-related whereas genes binding both receptors were significantly associated
with terms relating to synaptic plasticity and spine morphology. c, d Ingenuity Pathway Analysis (IPA) of the FS30 and BLPM MR ChIP-Seq data at FDR≤1.
This analysis confirmed the selective association of MR-bound genes with cilia-related structures and (dys)functions. As expected, due to the constant
nature of the majority of these cilia-related genes, the FS30 (c) and BLPM (d) associations showed very similar results. The number of genes within the
dataset relating to each GO term (a, b) or IPA category (c, d) is provided next to the corresponding bar. Source data are provided in the Source Data File.
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Fig. 7 Ingenuity Pathway Analysis (IPA) analysis of MR and GR ChIP-Seq data. IPA analysis was conducted on MR and GR ChIP-Seq FS30 (a, c, e, g, i)
and BLPM (b, d, f, h, j) data sets at FDR ≤ 0.1. The graphs represent pathways significantly associated with differentially bound MR- and GR-binding genes
(dark blue and light blue bars, respectively) for top terms relating to Cell Morphology (a, b), Cell to Cell Signalling (c, d), Cell Development and Movement
(e, f), Behavior (g, h), and Neuropsychiatric Diseases (i, j). The number of genes within the dataset relating to each term is provided next to the
corresponding bar. The Z-score was determined to infer the activation state of the gene within the molecular network. Z-scores of >+2 indicate that the
gene is considered significantly activating within the network, whereas scores of <-2 are regarded as significantly inhibiting. Source data are provided in the
Source Data File.
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Camk2a and Hif3a GREs under FS30 and BLPM conditions
(Supplementary Fig. 7a, b, d, e, g, h) and no changes in MR
binding to Ift57 and Cep41 (Supplementary Fig. 7j, m). As
expected, GR showed very low enrichment at the cilia genes (B/
I=1-2 (Supplementary Fig. 7k, n), i.e. similar to IgG negative
controls12 (Supplementary Fig. 8e–h) but did show a small, but
statistically significant increase in binding at both cilia genes
due to the circadian rise (Supplementary Fig. 7k, n). RNA
analysis by RT-qPCR of these genes in hippocampus tissues
collected under BLAM, FS60 (peak time of responsive hnRNAs
under study) and BLPM conditions revealed significant
increases in Ptk2b, Camk2a and Hif3a hnRNA levels, but not
Ift57 and Cep41 hnRNA levels (Supplementary Fig. 7c, f, i, I, o).
Despite the substantially higher corticosterone levels in rats
killed at FS30 in the PM, there was no additional enhancement in
MR and GR binding at Ptk2b and Camk2a GREs (Supplementary
Fig. 7a, b, d, e), possibly indicating attainment of a ceiling effect.
The hnRNA levels obtained under these conditions corresponded
with the MR and GR binding responses (Supplementary Fig. 7c,
f). Our observations regarding Ptk2b and Camk2a, however, were
not universal for all stress- and circadian-responsive MR- and
GR-interacting genes. For instance, GR binding, but not MR
binding, to Hif3a GRE was significantly higher after FS in the PM
than after stress in the AM (Supplementary Fig. 7g, h), which
corresponded with the enhanced stress-evoked Hif3a hnRNA
responses in the PM as compared with the AM (Supplementary
Fig. 7i). Thus, it appears that stress responsiveness of genes over
the circadian cycle is gene dependent.
Gene-dependent effects of MR and GR antagonist treatment.
Subsequently, we determined if treatment with the MR antagonist
spironolactone (Spiro) and the GR antagonist RU486 would affect
MR and GR interaction with genes and gene expression. Under
BLAM conditions, RU486 increased binding of GR to Ptk2b and
Camk2a (Supplementary Fig. 9b, f), which may be the result of
the antagonist-GR complex still being capable of binding to these
genes, as previously described in vitro21,22. The GR antagonist
neither affected stress-induced GR and MR interaction with
Ptk2b and Camk2a nor influenced the hnRNA responses of these
genes (Supplementary Fig. 9c, d, g, h). Spiro had no effect on
either binding or RNA expression of Ptk2b and Camk2a (Sup-
plementary Fig. 9a–h). In contrast, the antagonist treatments
revealed distinct responses in the case of Hif3a verifying efficacy
(Supplementary Fig. 9i-l). RU486 blocked the stress-evoked
interaction of both GR and MR with Hif3a as well as the
stress-induced hnRNA response of this gene. Spiro treatment led
to a decrease in MR binding to Hif3a after stress but did not affect
GR binding under this condition. Unexpectedly, Spiro treatment
resulted in enhanced FS-induced Hif3a hnRNA responses (Sup-
plementary Fig. 8l) which correspond with the elevated plasma
Cort levels in these animals at FS30 (Supplementary Fig. 1e–g)
possibly enhancing GR-mediated effects on Hif3a. In addition, it
cannot be excluded that MR binding exerts an inhibitory effect at
this gene with Spiro administration resulting in diminished MR
binding and increased FS-induced hnRNA production. As
expected, in view of MR’s constant binding to ciliary genes, the















































































































































Fig. 8 Characterization of typical MR-only- and MR-&-GR-regulated genes involved in ciliary structure/function and neuroplasticity. Data were
generated by MR/GR ChIP-seq and RiboZero RNA-seq analyses. Two genes associated with MR-only binding (a–c) or MR-&-GR-binding (d–f) are shown
here which were selected for further investigation. a The fold changes in MR binding to Cep41 and Ift57 at FS30 and BLPM compared with BLAM levels are
shown. No GR binding was detected in any of the 4 individual samples. Changes in intronic (inRNA, b) and exonic (exRNA, c) RNA levels of Cep41 and Ift57
are shown. Values are expressed as a ratio of transcripts per million (TPM) under BLAM conditions. There were no significant changes. The synaptic
plasticity-related genes Ptk2b and Camk2a contain stress- and circadian-responsive MR and GR peaks. d The fold-changes in MR and GR binding at FS30
and BLPM compared with BLAM levels are shown. *FDR≤0.05 (DiffBind). Changes in intronic (inRNA, e) and exonic (exRNA, f) RNA levels of Ptk2b and
Camk2a are shown. Values are expressed as the ratio of transcripts per million (TPM) over BLAM levels. *FDR < 0.05 (EdgeR). Source data are provided in
the Source Data File.
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responses of Ift57 and Cep41 (Supplementary Fig. 9m–r). The
results regarding Ptk2b, Camk2a and Hif3a show that the impact
of antagonist treatment is gene-dependent. This gene dependency
may be due to differences in the interaction of antagonist-
receptor complexes and (epigenetic) co-factors with the local
chromatin, as well as possible compensatory mechanisms invol-
ving other transcription factors.
RFX3 binds to the MR-binding site in Cep41 but not to the
MR/GR-binding site in Ptk2b. The cilium-related gene Cep41
showed only (constant) MR binding and no GR binding in any
sample (Fig. 8; Supplementary Data 1, 2, 11). Examination of the
binding motifs within the MR binding peak of this gene uncov-
ered an RFX binding motif (Peak location: Chr4:58006735-
58007214, RFX motif location: 282-300; Supplementary Data 5)
but no GREs (NR3C1/2, AR motifs). This observation corre-
sponds with our genome-wide FIMO analysis showing that the
RFX motif is among the top-5 motifs within constant MR (non-
GRE) peaks (see text above). The presence of the RFX motif in
the MR binding peak of Cep41 is of interest as it is well-known
that RFX transcription factors (particularly RFX1-4) are of crucial
importance for cilium structure and function23–26. Our RNA-seq
data show that the Rfx3 gene is constitutively, highly expressed in
the hippocampus (Supplementary Tables 6 and 7). To sub-
stantiate the significance of the RFX site within the Cep41 MR-
binding peak, we conducted an RFX3 ChIP on hippocampus
chromatin collected under BLAM and FS conditions and ran
qPCR analysis for the ‘MR-binding’ locus (as in Fig. 8 and Sup-
plementary Figs. 7 and 8), which encompasses the RFX motif. As
a control, we conducted qPCR analysis on RFX3 ChIP DNA
targeting the ‘MR/GR-binding’ locus in Ptk2b which according to
our FIMO analysis contains GREs (Peak location:
Chr15:42862802-42863358; NR3C1/2 motif locations: 111-127,
189-205, and 299-315) but also RFX motifs (Chr15:42862802-
42863358; RFX motif location: 16-32 and 174-189). Figure 9
shows that RFX3 is highly enriched at the ‘MR-binding’ locus in
Cep41 (B/I: 20-30; Fig. 9a) but inconsequential at the ‘MR/GR-
binding’ locus in Ptk2b (B/I: 1-1.5; Fig. 9b). Thus, despite the
presence of RFX motifs, RFX3 did not bind to Ptk2b. RFX3
binding to Cep41 was constantly high as it did not change after
acute stress (Fig. 9a). These data confirm that at MR-binding loci
within ciliary genes, it is not just MR that is binding but RFX3
and/or possibly other RFX factors are binding as well. These
observations substantiate a possible joint role of MR and RFX
transcription factors in the regulation of ciliary genes.
Critical role of MR in neuronal differentiation and ciliogenesis
in human foetal neuronal progenitor cells. We used human
foetal neuronal progenitor cells (hfNPCs) to investigate if the MR
was playing a functional role in ciliogenesis, an important part of
neuronal differentiation. As ciliogenesis has been shown to be
linked to neuronal differentiation27,28 and our GO and IPA
analyses revealed a strong link between MR and ciliary genes
(Fig. 6), we postulated that hfNPCs would show cilia formation
during the neuronal differentiation process. Figure 10a shows that
proliferating hfNPCs (as indicated by incorporation of the thy-
midine derivative EDU (5-Ethynyl-2′-deoxyuridine)) express
Nestin, a filament protein expressed in stem cells, but not MRs.
After neuronal differentiation, however, the young neurons
(stained by Tuj1) express MR protein abundantly (Fig. 10b).
Typically, differentiation of hfNPCs is induced by mitogen (EGF/
FGF-b) withdrawal and plating on a suitable substrate. Many
years ago, it was empirically determined that the steroid hormone
progesterone is required for this process29 and, nowadays, it is a
typical component of commercially available neuronal
supplements. Progesterone, however, can act as an agonist or
antagonist of the MR30,31. Therefore, given that our IPA analysis
had revealed a marked role of MR in neuronal differentiation, we
postulated that progesterone acts through MRs on this cellular
process. To test this postulate, proliferating hfNPCs were cultured
using commercial ‘N2’ supplement (containing 20 µM proges-
terone) or in home-made supplement of identical composition as
the N2 supplement (indicated as ‘Prog’ in Fig. 10c–e) or with
home-made N2 in which progesterone was either omitted (no
steroid; ‘N.S.’) or replaced by the MR agonists, the glucocorticoid
hormone corticosterone (‘Cort’, 0.1 µM) or the mineralocorticoid
hormone deoxycorticosterone (DOC, 0.01 µM) (Fig. 10c–e).
Figure 10c–e show that administration of Cort or DOC mimicked
the effect of progesterone enabling neuronal differentiation,
whereas omission of any of these hormones completely blocked
this cellular process. Representative images of Tuj1- and DAPI-
stained neurons cultured under N2, N.S. or DOC conditions are
shown in Fig. 10c. The formation of cilia (as visualized by ade-
nylate cyclase 3 (AC3) staining (Fig. 10g)) mirrored the pattern of
neuronal differentiation: ciliogenesis occurred in the N2, pro-
gesterone, Cort and DOC conditions but not if steroids were
omitted (Fig. 10e). These experiments indicate that agonist action
via MR is required for neuronal differentiation and ciliogenesis in
hfNPCs.
To provide additional evidence for a critical role of MR in
neuronal differentiation and ciliogenesis, hfNPCs were differ-
entiated in the presence of commercial N2 supplement and the
MR antagonist Spiro. Addition of Spiro (0.1 or 10 µM) resulted in
a dose-dependent decrease in nuclear MR staining in the young
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Fig. 9 RFX3 ChIP-qPCR analysis. RFX3 ChIP-qPCR analysis was conducted
on Cep41 (a) and Ptk2b (b) using hippocampal chromatin of rats killed
under BLAM conditions or at different times after FS. qPCR was conducted
using the same DNA primers as in Supplementary Fig. 7 & Supplementary
Table 2. The graphs show mean enrichment ((Bound/Input (B/I); mean ±
SEM) of RFX3 binding to the genes Cep41 (a; n= 4 biologically independent
samples) and Ptk2b (b; n= 4 biologically independent samples). Statistical
analysis: Oneway ANOVA: (a) F(4,15)= 0.4308, p= 0.7843; (b) F(4,15)
= 2, p= 0.1230. Source data are provided in the Source Data File.
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Fig. 10 MR-mediated control of differentiation of and ciliogenesis in human foetal neuronal progenitor cells (hfNPCs). Neurospheres were prepared
from human foetal cortex tissue and immuno-stained during proliferation (a) and following differentiation (b). The white bar in the various panels indicates
50 µm. a Positive staining for the proliferation marker ethynyl deoxyuridine (EDU (lime green)) and the stem cell marker Nestin confirm the proliferative
state of the cells whilst MR staining is absent. b Following initiation of differentiation, neuron-specific class III beta-tubulin (Tuj1 (magenta)) identifies
differentiated young neurons which abundantly express nuclear MRs (lime green). Immunofluorescent images are representative of 3 independent
experiments. c–e Tuj1-specific staining (magenta) confirms that hfNPCs require the presence of progesterone (Prog), corticosterone (Cort) or
deoxycorticosterone (DOC) for both neuronal differentiation and cilia expression. Absence of any steroid (N.S.) completely abolishes these processes (Tuj1
(Neurons): mean ± SEM, n= 3 independent replicates for all experimental groups; Oneway ANOVA: F(4,10)= 82.98, p < 0.0001; Cilia: mean ± SEM, n= 4
independent replicates for ‘N2’, Cort and DOC; n= 2 independent replicates for N.S. and Prog. Oneway ANOVA: F(4,11)= 4.508, P= 0.0212; post-hoc
Dunnett’s test was not conducted as N.S. group is zero neurons/cilia and, in case of cilia, the N.S. and Prog groups were n= 2). Images in c are
representative of 3 independent experiments. f Representative images (of 6 (Veh.), 4 (Spiro 0.1) and 5 (Spiro 10) independent experiments) indicating that
the presence of MR-selective antagonist spironolactone (0.1, 10 μM) causes a dose-dependent inhibition of neuronal differentiation (Tuj1-specific staining,
magenta). g Representative image (of 4 independent experiments) of a cilium (adenylate cyclase 3 (AC3) staining, lime green, indicated by the arrow) on a
young Tuj1-positive neuron. h, i Quantification of neurons and cilia confirms inhibition by spironolactone: Tuj1 (Neurons), mean ± SEM, n= 6 independent
replicates (Vehicle), 4 independent replicates (Spiro 0.1), and 5 independent replicates (Spiro 10)): Oneway ANOVA: F(2,12)= 9.637, p= 0.0032, post-
hoc Dunnett’s test (two-sided): *p= 0.0029; Cilia, mean ± SEM, n= 5 independent replicates (Vehicle), 6 independent replicates (Spiro 0.1), and 4
independent replicates (Spiro 10): Oneway ANOVA: F(2,12)= 8.296, p= 0.0055, post-hoc Dunnett’s test (two-sided): *p= 0.0071). Source data are
provided in the Source Data File.
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images of the Tuj1-stained neurons differentiated under Spiro or
vehicle conditions. Quantification of neurons and cilia revealed
that inclusion of Spiro dose-dependently inhibited neuronal
differentiation and cilia formation underlining the requirement of
MR action in these processes (Fig. 10h, i).
Discussion
We used a direct approach to study physiologically relevant
effects of GCs on the rat hippocampus by delineating the MR-
and GR-interacting genes and their transcriptional activity under
BLAM, BLPM and acute FS stress conditions. Almost all GR
peaks responded to the PM and stress conditions whereas only
approximately three-quarters of MR peaks were responsive. The
other MR peaks remained unchanged. Elaborate pathway ana-
lyses clearly indicated functional differences between constant
MR-associated genes and stress/circadian-responsive MR/GR-
associated genes. We discovered that the constant MR peaks were
associated with genes that encode ciliary proteins. Using hfNPCs,
we could demonstrate that MRs are indeed functionally involved
in neuronal differentiation and ciliogenesis. In contrast, the
responsive MR/GR-associated genes are strongly involved in
neuroplasticity processes, learning and memory, and several
neuropsychiatric disorders. Our analyses also show that there is
similarity between the cellular and behavioural processes regu-
lated by MRs and GRs after stress and during the PM phase of the
day. Thus, our study provides novel insights into the genomic
regulatory mechanisms and pathways engaged by GCs under
baseline and stress conditions in the hippocampus.
Previous work aiming to gain insight into the effects of GCs on
the brain often used indirect, endocrine (e.g. adrenalectomy and
GC substitution) approaches. In addition, MR and GR gene
deletion strategies have been applied. These studies have been
important in contributing to our understanding of cellular and
behavioral processes in which GCs could be involved. These
approaches, however, have not resulted in comprehensive
knowledge about the genes, thus the molecular mechanisms,
underpinning the MR- and GR-mediated GC effects and their
gene transcriptional implications under physiological conditions.
Therefore, we studied these effects through assessment of MR and
GR interaction with the hippocampal genome in combination
with gene transcriptional responses under physiologically relevant
GC conditions (BLAM, BLPM and acute stress). This approach
has delivered direct, parallel read-outs of MR- and GR-bound
genes as well as RNA expression under these biologically relevant
conditions. Although both hippocampal receptors bind corticos-
terone, our data reveal that, at the genomic level, MRs and GRs
behave quite differently. This difference goes beyond their well-
known difference in ligand binding affinity7,32. We found that
whereas almost all GR peaks respond to the altered physiological
condition, this only applied to 72% of MR peaks. Whilst the
responsive GR peaks appear to act predominantly via GREs
(>95% of stress/circadian-responding peaks contain a GRE), this
is less the case with the responsive MR peaks (~70% of these
peaks contain a GRE). It should be added that not all GREs
within the genome are equally accessible12. In general, GRs have
been behaving predictably: With rising circulating corticosterone
levels due to stress or circadian drive, GR occupancy by ligand
increases resulting in increased binding of GRs to accessible GREs
within the genome. Regarding MR the situation is more complex.
Due to their very high ligand binding affinity, MRs are always
highly occupied7,32. Nevertheless, despite this high occupancy
and their intra-nuclear localization33, we showed that MR
interaction with the GC target genes Fkbp5, Per1 and Sgk1 is low
under BLAM conditions and only increases substantially at
BLPM or post-stress12. We postulated that the BLPM and stress
conditions render GREs and other sites accessible for MR, most
likely as a result of epigenetic and other mechanisms10,12 and is
likely to be a factor in the responsiveness of 72% of MR peaks.
The other, constantly bound, MR peaks did not respond to BLPM
or stress conditions and were less likely to contain GRE motifs.
We demonstrated that RFX3 binds the RFX motif in the (con-
stant) MR binding locus in Cep41. This finding indicates that
constant MR binding at loci may involve interaction with other
transcription factors like RFX3. Moreover, the RFX site within the
MR/GR-binding, GRE-containing locus within Ptk2b was not
accessible for RFX3. These observations show that control of
accessibility of transcription factors to their target motifs in the
genome is regulated in a gene-, transcription factor-, and motif-
dependent manner. Therefore, each transcription factor interac-
tion with the genome is unique and may require subjective
experimental verification.
The incidence of MR and GR binding to loci that do not
contain a GRE element prompts the question whether these
receptors bind directly or indirectly to such non-GRE motifs. An
indirect action of MR and/or GR at a non-GRE motif would
require the local binding of the intrinsic transcription factor to
such motifs. As mentioned, RFX3 binds to the RFX site in the
promoter of Cep41, thus MR may be binding in this region
through interaction with RFX3. Co-binding of MR or GR can be
envisaged at other sites such as EGR, KLF, STAT and FOX as our
RNA analyses revealed the induction of the respective tran-
scription factor RNAs EGR1, EGR2, EGR4, KLF2, KLF4, KLF9,
KLF13, KLF15, STAT3, STAT5b and FOXO3 after stress and at
BLPM (Supplementary Data 8 and 9). Previously, we showed that
FS induces EGR1 in distinct hippocampal neurons; a process
requiring a confluence of NMDA receptor-mediated ERK1/2,
Elk-1, MSK1/2 and (non-genomic) GR signaling, formation of the
dual histone mark H3K9ac-S10p at the gene promoter, as well as
DNA demethylation of the promoter and 5′-untranslated regions
of the Egr1 gene34–36. Moreover, Chen et al. recently provided
evidence that GR and EGR1 interact at the EGR motif within the
Bdnf gene37. Such interactions have also been reported for GR
and STAT3/STAT5b, and GR and KLF2/KLF4/KLF9 at STAT
and KLF/GRE binding motifs, respectively, in various cell
types38–41. We found that a number of these transcription factor
genes (i.e. Klf2, Klf4, Klf7, Klf9, Klf13, Klf15) showed increased
MR and GR binding after stress or at BLPM (Supplementary
Data 4). Thus, MR/GR action involves direct interaction with
GRE motifs and indirect interactions via other transcription
factors with their intrinsic binding motifs, whereby GCs can
enhance the latter mode of interaction through induction of the
respective transcription factor.
In parallel to assessment of genome-wide MR and GR binding,
we determined in- and exRNA responses to acute FS stress and
the BLPM condition in the rat hippocampus. This approach
would reveal if changes in MR and/or GR binding to genes could
be linked to changes in transcription of these genes. Previous
ChIP-seq studies adopting an endocrine approach did not include
assessment of RNA responses and were analysed based on earlier
rat genome versions (Rn442,43). We found significant correlations
between circadian-responsive changes in MR and GR binding
and the in- and exRNA responses of these MR- and GR-binding
genes. Regarding responses to stress, only responsive changes in
MR correlated significantly with altered inRNA expression. The
higher occurrence of correlations among the inRNA data may be
expected as these data are more reflective of dynamic transcrip-
tional activity. The observations regarding the higher correlations
in MR and circadian data as compared with GR and stress data
are, however, surprising. Apparently, the stress paradigm caused
greater variation in the receptor and RNA data than circadian
variation. This could be because the stress response is induced by
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-24967-z ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:4737 | https://doi.org/10.1038/s41467-021-24967-z | www.nature.com/naturecommunications 15
an unpredictable external environment and, therefore, likely to
mobilize additional genomic effectors, such as transcription fac-
tors other than MR or GR and/or epigenetic mechanisms, which
impact on gene transcriptional output. It is likely that multiple
transcriptional waves of regulation occur after stress making it
hard to correlate the magnitude of all the transcriptional
responses back to the initial MR and GR binding events. Con-
versely, the circadian drive is an endogenous process occurring in
a controlled environment, therefore, transcriptional responses
may be more predictable. It is unlikely that the optimal time point
of the response to stress was missed as we conducted an extensive
time-course analysis of the response. Presently, we are only at the
beginning of mapping the factors and mechanisms which work
alongside MR and GR in the execution of these molecular and
physiological processes. Our previous work points to the possible
involvement of the transcription factor CREB and the dual his-
tone modification H3K9ac-S10p in acute FS-induced
responses35,44. Our present results show, however, that there
are still many unknowns in the genomic action of MR and GR in
physiological responses that require clarification.
The complexity of physiological gene regulation is exemplified
in the studies in which we compared FS stress-induced effects
between the AM and PM time points or investigated the effects of
MR and GR antagonists at the individual gene level. In these
studies, we compared MR and GR binding and hnRNA changes
in the stress- and circadian responsive genes Ptk2b, Camk2a and
Hif3a. In the AM and PM stress experiment, the MR and GR
binding pattern to these genes was largely similar as was the
hnRNA responses of Ptk2b and Camk2a. The hnRNA response of
Hif3a was, however, clearly different as this gene, in contrast to
Ptk2b and Camk2a, showed an augmented stress response in the
PM, compared with stress effects in the AM. Regarding Hif3a, its
PM hnRNA stress response corresponds with the amplified
plasma corticosterone and GR to Hif3a GRE binding responses.
Such alignment is not observed for Ptk2b and Camk2a. These
observations indicate that the hippocampal Hif3a gene is differ-
ently regulated than the other two genes. The enhanced respon-
siveness of Hif3a in the PM may be due to an increase in the
number of hippocampal cells in which the Hif3a GRE would be
available for GR binding, but apparently not MR binding.
According to our data, there seems to be no change in the
availability of Ptk2b and Camk2a GREs. Nevertheless, these data
show, irrespective of underlying mechanisms, that, at the indi-
vidual gene level, transcriptional activity is controlled in a gene-
dependent, and most likely cell-dependent, manner. Our data also
underline that assessment of a GC-responsive gene is not repre-
sentative for all GC-responsive genes and plasma GC responses
are not a universal predictor of MR/GR binding and RNA
responses in GC target genes. The latter notion strengthens our
conclusions made in a previous study based on a comparison of
different stressors12.
The receptor antagonist experiments provided additional evi-
dence that stress-evoked gene regulation is gene dependent. The
observation that the GR antagonist RU486 inhibited FS-induced
MR binding to Ptk2b, Camk2a and Hif3a seems contradictory.
Previously, however, we have shown, that MRs and GRs can
heterodimerize at GREs12; therefore, the diminished MR binding
after stress in the presence of RU486 may be due to an inability of
the RU486-bound GR to heterodimerize with MR45. In case of
Ptk2b and Camk2a, but not Hif3a, the RU486-bound GR is able
to bind to GREs in both the BLAM and FS conditions. As the
local chromatin structure and molecular co-factors are known to
modulate GR action46, the observation of distinct GRE-binding
properties of RU486-GR at genes further highlights that such
molecular mechanisms are engaged in a highly gene-dependent
way. Except for an inhibition of stress-induced MR binding to
Hif3a GRE and enhanced Hif3a hnRNA responses, Spiro had
little effect on MR/GR binding and hnRNA levels. This may be
expected given that hippocampal MRs are always highly occupied
by endogenous corticosterone7,32 preventing any Spiro from
receptor binding. The enhanced stress-induced Hif3a hnRNA
response in Spiro-treated rats may be due to elevated plasma GC
levels in these animals acting through GRs, but this needs to be
clarified by future work. Both RU486 and Spiro resulted in
increased FS-evoked plasma GC levels, as expected33,47, pre-
sumably as a result of feedback inhibition. In conjunction, the
results of the AM and PM stress experiment and receptor
antagonist experiment on selected genes underline the gene-
dependency of GC-regulated transcription.
IPA analysis revealed the activational role (based on >2 Z-
scores) of stress and PM responsive MR- and GR-associated
genes in neuronal morphology, development, and cell-to-cell
communication. Genes were found with well-known roles in
neuroplasticity and synaptic processes (e.g. dendritogenesis, LTP,
LTD) like Ptk2b, Gria1, Grin2b, and Dlgap1; all genes previously
unknown to be directly regulated by GC receptors. We also
observed an association of responsive MR and GR peaks with
genes known to be involved in cognition, learning and memory,
and, interestingly, -hippocampus-associated- spatial learning and
memory processes. It has been known for many years that GCs
play a critical role in hippocampus-associated adaptive behaviors
such as observed in the FS test, Morris water maze learning, and
contextual fear conditioning1,4,12,35,48–51. Based on GC effects on
(electro-)physiology52–54 and behavior1,49,50,55,56, the notion has
been developing that these hormonal effects are the result of
molecular and cellular neuroplasticity changes. Presently, how-
ever, there is only limited data available regarding the GC-target
genes involved in these neuroplasticity changes. Our integrative
sequencing methodology reveals potential target genes which may
be mediating the link between glucocorticoid action and the
consequences for neuroplasticity. Our work provides evidence
that GCs affect physiology and behavior through MRs and GRs
acting on genes thereby precipitating the molecular and cellular
changes underpinning the observed biological changes.
MR- and GR-bound genes also show enrichment of terms
related to mental disorders including depressive disorder,
bipolar disorder and schizophrenia spectrum disorders (SSDs).
It has been known for many years that depressive and bipolar
patients often show disturbances in GC secretory patterns. They
exhibit impaired negative GC feedback efficacy as shown in the
dexamethasone (DEX) suppression test and DEX/cortico-
tropin-releasing hormone (DEX/CRH) test57–60. A disrupted
circadian secretion of GCs has been observed as well61, parti-
cularly in bipolar patients62,63, which may be of interest in view
of our observation that we only found significant associations in
BLPM MR and GR ChIP-Seq data. In fact, corticosteroid
receptor dysfunction is thought to be a key factor in the
development of major depressive disorder64. Hence, hippo-
campal MR and GR have been shown to be targets of anti-
depressant drugs65,66. A role of GCs in SSDs is less established
but evidence has been accumulating indicating a role of GCs
both in early life as well as in adulthood in increasing vulner-
ability for developing schizophrenic symptoms67,68. Evidently,
IPA unearthed a substantial number of genes, like Disc169,
Syn370, Synpo71, Grin2a, Gria1, Foxo3, and many others which
reportedly have been shown to be linked with depressive dis-
order, bipolar disorder and/or SSDs. Of key importance is that
most of these genes have never before been associated with MR
and/or GR interaction, hence were unknown to be potentially
regulated by GCs. Therefore, our work provides the opportu-
nity and rationale for the investigation of the genomic basis of
GC-evoked vulnerability of these mental disorders.
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Both the FS30 and BLPM conditions show enrichment of
similar pathways. These include the cellular, behavioral and
neuropsychiatric functions, the number of associated genes, and
the Z-score output. With few exceptions, there is also consider-
able parallelism between MR- and GR-associated functions. Our
IPA results correspond with the high degree of overlapping MR
and GR peaks responding to the FS and BLPM conditions. This
outcome is surprising as stress and circadian variation involve
very distinct physiological and behavioral responses. Never-
theless, our data show that GCs secreted during these responses
act on very similar genes. Therefore, these hormones appear to
play a generally supportive or facilitatory role after stress and
during the active phase of the circadian cycle: adaptation and
learning and memory post-stress, and anticipatory preparation
for the active circadian phase. Both situations appear to require a
highly similar GC-regulated genomic response. Therefore, based
on this outcome, GCs should not be synonymously called ‘stress
hormones’ but rather ‘activity-associated hormones’. This desig-
nation would correspond with the circumstance that GC secre-
tion occurs during both adverse (physical and psychological
stress72,73) and pleasurable (e.g. sex74, voluntary exercise75) cir-
cumstances, hence circumstances involving physical and/or
mental activity.
Our study discloses unique roles for MR in the hippocampus
regarding neuronal differentiation and ciliary structure and
function. IPA analysis revealed that, both under stress and BLPM
conditions, MR, but not GR, has an activational role in neuronal
differentiation. Previously, MRs have been reported to exert
neuroprotective and pro-survival effects in dentate gyrus neurons
in vivo76,77. Recently, an additional role for MR in controlling the
neuronal phenotype of CA2 neurons was reported78. Further-
more, our analyses uncovered an inhibitory role (as indicated by a
significantly negative Z-score) of MR-targeted genes in ‘neuro-
degeneration’. These observations agree with a role of MRs in
neuroprotection and neuronal differentiation. Moreover, our
results provide a deeper understanding of the MR-target genes
participating in these effects. Our study also discovered the
association of MR with ciliary genes encoding proteins involved
in cilium structure (e.g. axoneme, transition zone, centrosome),
cilium assembly, and intraflagellar transport. Cilia are hair-like
protrusions from the cell body, thought to be involved in neu-
ronal development and communication, but their function is still
largely unknown26,79. Primary cilia, however, have been shown to
be critical for hippocampus-associated functions80. Hence, abla-
tion of these organelles from hippocampal neurons through
deletion of certain ciliary genes results in severe disruption of
dentate gyrus neurogenesis and hippocampus-dependent beha-
viours (contextual fear conditioning, spatial object
recognition)27,81–83. Our study shows that, in the majority of
cases, MR was constitutively bound to ciliary genes in genomic
regions devoid of GREs but with RFX motifs present. We report
here that the RFX motif in the MR binding peak within ciliary
gene Cep41 indeed binds RFX3 supporting this MR-RFX asso-
ciation. These observations are of interest because: 1. They indi-
cate that MR binding within this gene and possibly other ciliary
genes occurs in conjunction with RFX transcription factors, like
RFX3; and 2. The RFX motif in Cep41 is accessible for RFX
transcription factors (in contrast to the one in Ptk2b) which are
known to be of critical importance for cilia structure and
function23–26. Future work should investigate how MR and RFX
molecules interact at RFX sites within ciliary genes.
Although our work identified an association of MRs with genes
involved in neuronal differentiation and structure and function of
cilia, a direct functional link had not been demonstrated, neither
by us nor by others. Therefore, we pursued the functional role of
MR in neuronal differentiation and ciliogenesis in hfNPCs. In
their proliferating state, these cells do not express MRs which
corresponds with the absence of these receptors in progenitor
cells in the subgranular zone of the dentate gyrus84,85. Triggering
of the differentiation process in our hfNPCs resulted in the
expression of MRs in the young neurons. Occupancy and acti-
vation of these receptors was a critical necessity as omission of an
MR agonist completely blocked neuronal differentiation as well as
ciliogenesis. Many years ago, it had been empirically determined
that progesterone is a critical constituent of the neuronal sup-
plement (‘N2’29). We show that the human MR agonists corti-
costerone and DOC mimicked the effects of progesterone on the
differentiation of hfNPCs into neurons and the expression of cilia
in these cells. Moreover, Spiro strongly inhibited the differentia-
tion and ciliogenesis processes further strengthening the func-
tional link between MRs and these processes. Gass et al.76 have
previously shown that mice with MR gene deletion have a
decreased number of granular neurons in their dentate gyrus.
This was not observed in GR gene deleted animals76. Due to the
MR deletion, progenitor cells and/or neuroblasts may be unable
to differentiate into neurons. Inability to generate cilia may be a
critical factor in the differentiation process as deletion or
impairment of ciliary genes results in major disturbances in
embryonic neurodevelopment and adult neurogenesis27,28,82,86,87.
Furthermore, dentate granular neurons require agonist-occupied
MRs for their viability88,89. Together, these MR-dependent
mechanisms explain the loss of dentate granular neurons in the
MR knock-out mice. Our study provides the identity of the
neuronal differentiation- and ciliary genes targeted by MR
allowing follow-up studies to gain deeper insight into these
mechanisms. Moreover, given the nature of the hfNPCs used, our
findings may trigger research on the role of MR in neuronal
development during embryogenesis. Our IPA analysis also points
to a role of GR, in addition to MR, in maturation, development
and morphology (e.g. dendrite- and neuritogenesis) of neurons.
Thus, it appears that MRs play a critical role in the early stages of
neuronal differentiation whereas both MRs and GRs orchestrate
the morphological development and adaptation of (young) neu-
rons in response to life-imposing activities.
GCs are known to promote resilience, adaptability and cog-
nitive performance to cope with challenges from the environ-
ment, but the underpinning genomic mechanisms driving the
required physiological and behavioral changes were largely
unknown. The present work shows that these hormone actions
are mediated by hippocampal MRs and GRs acting at the geno-
mic level on multiple molecular and cellular aspects of neuronal
plasticity, in response to an acute stressful challenge as well as
anticipatory at the start of the active phase. Our work also reveals
a role for GCs acting predominantly and constitutively through
MR on ciliary genes which likely involves interactions of this
receptor with RFX transcription factors. The functional relevance
of the MR-ciliary gene link was observed in differentiating
hfNPCs which aligns with the involvement of primary cilia in
embryonic and adult neurogenesis. Collectively, our work
underlines the multifarious complexity of GC action in the brain
and provides the molecular basis for the study of the functional
role of these hormones under physiological and pathological
conditions.
Methods
All chemicals used below were from Sigma, UK unless otherwise specified.
Animals and stress procedures. All animal work was approved by the University
of Bristol Ethical Committee and the Home Office of the United Kingdom (Animal
Scientific Procedures Act, 1986, UK).
Adult male Wistar rats (150–175 g on arrival) were purchased from Envigo, UK
and group-housed (2–3 per cage). Rats were housed under standard lighting (lights
on 05:00–19:00 h, approximately 80–100 Lux) and environmentally controlled
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conditions (temperature 21 ± 1°C; relative humidity 40–60%) with food and water
available ad libitum. Rats were randomly assigned to cages and these were labelled
according to a random sequence (https://www.random.org/sequences/) to avoid
subjective bias. Due to the nature of the animal work, blinding was not possible at
this stage. All rats were handled daily for at least 5 days prior to experimentation to
reduce non-specific handling stress on the day of the experiment. Baseline rats were
killed straight from their home-cages between either 7-9am (circadian trough,
BLAM) or 5-7 pm (circadian peak, BLPM). Alternatively, rats were forced to swim
for 15 min in 25°C water, towel dried, returned to their home cage and killed 30,
60, 120, 180 or 360 minutes after the start of swimming (FS30, FS60, FS120, FS180,
and FS360, respectively). Sample size was determined based on previous work; n=
4 per group (BLAM, FS30, BLPM) for ChIP experiment (tissue of 2 rats pooled per
n; 24 rats in total) and n= 9 per group for RNA (tissue of 1 rat per n; 63 rats in
total). Following quick isoflurane anaesthesia (<10 sec) and decapitation, the brain
was removed and the hippocampus dissected on an ice-cold steel box.
Hippocampus tissues were snap-frozen in liquid N2 and stored at -80 °C. Trunk
blood was also collected at the time point of decapitation and stored on ice in tubes
containing EDTA and aprotinin for determination of the plasma corticosterone
concentration by radioimmunoassay (RIA).
Subsequent validation experiments were performed in the same manner as
above but on tissue collected from distinct cohorts of animals. The first experiment
was designed to determine if the observed responses to acute stress and the
circadian rise were a function of CORT levels or a qualitative difference between
the two conditions. Rats were killed under BLAM (8-11am) or BLPM (5-7 pm)
conditions or 30 min (for ChIP) or 60 min (for RNA) after FS exposure performed
during the AM or PM. Sample size was determined based on previous work12 and
initial sequencing experiments; n= 4 per group for ChIP (tissue of 2 rats pooled
per n; 32 rats in total), n= 8 per group for RNA (32 rats in total)). To investigate
the effect of MR and GR receptor antagonists, spironolactone (MR antagonist, 50
mg/kg) or RU486 (GR antagonist, 100 mg/kg), respectively, were administered to
rats via voluntary dosing which allows the virtually stress-free administration of
drugs. Voluntary dosing was conducted by offering rats the vehicle (50%
condensed milk, 1 ml) in 1 ml syringes through the bars of the homecage for 5 days
prior to day of experimentation. On each day, rats were subsequently handled as
described above to reduce non-specific handling stress. On the experimental day,
antagonists were mixed into diluted condensed milk/H2O (50:50 v/v, 1 ml) and
given to rats in the same manner (100% uptake). 60 min after drug (or vehicle)
administration rats were subjected to a 15-min FS challenge as detailed above or
left in their home cage as non-stress baseline controls. Rats were then killed either
30 min (for ChIP) or 60 min (for RNA) after the start of FS or at an equivalent
timepoint (90 min for ChIP; 120 min for RNA) after drug/vehicle administration
for non-stress controls. Sample size was determined based on initial sequencing
experiments and pilot drug administration tests; n= 4 per group for ChIP (tissue
of 2 rats pooled per n; 48 rats in total), n= 6 (for Spiro) -8 (for RU486) per group
for RNA (56 rats in total). Finally, given that FIMO analysis identified the RFX
binding motif in a high percentage of MR-only binding peaks which lacked a GRE,
we performed a validation experiment to determine if RFX3 was also binding in
these regions. Groups of rats were killed at BLAM, FS15, FS30, FS60 and FS180 as
described above (n= 4 per group (tissue of 2 rats pooled per n); 40 rats in total)).
This experiment provided the chromatin to perform the RFX3 ChIP timecourse
(Fig. 9).
These experiments were included to strengthen the conclusions drawn from this
paper by providing independent biological confirmation of the sequencing results,
whilst also providing additional new information regarding the influence of stress
during the circadian rise and the effect of specific receptor antagonists. In total,
across all experiments included in this publication 295 rats were used. Confounder
effects were minimised by experimental design.
Measurement of plasma corticosterone by radioimmunoassay (RIA). Blood
samples were centrifuged at 1500 × g and 4 °C for 30 min to separate plasma, which
was collected into fresh tubes and stored at -80°C until analysis. Plasma corti-
costerone concentration was determined using a commercial RIA kit (MP Bio-
medicals) following manufacturers guidelines.
ChIP-Seq sample preparation, library construction, sequencing, mapping and
data analysis. Sample preparation — Four independent biological replicates were
sequenced per condition; each replicate consisting of the dissected hippocampi
from two animals. Frozen hippocampus tissues were cross-linked in a buffered 1%
formaldehyde solution containing inhibitors, sonicated and chromatin prepared.
ChIP was performed by incubation of antibodies (10 µl/ChIP sample) against either
MR (MR H-300, sc11412x, Santa Cruz) or GR (GR H-300, sc8992x, Santa Cruz)
with 200 µl chromatin. The specificity of these antibodies for their target has been
confirmed by pre-absorption tests and Western analyses previously12. Inputs were
prepared from 20 µl of the original chromatin sample by reversing crosslinks
(NaCl, final conc. 200 nM, at 65°C overnight) and treatment with RNase A (60 µg/
ml, 1 h at 37°C) and proteinase K (250 µg/ml, overnight at 37°C). DNA was
purified using Qiagen PCR purification kit as per manufacturer’s instructions
(Qiagen, Germany).
ChIP-seq library construction and sequencing—DNA was quantified using Qubit
(Invitrogen) and the size profile analysed on the 2200 or 4200 TapeStation (Agilent,
dsDNA HS Assay). Input material was normalised to 5 ng prior to library
preparation. Automated library preparation was performed using the Apollo prep
system (Wafergen, PrepX ILMN 32i, 96 sample kit) and standard Illumina
multiplexing adapters following manufacturer’s protocol up to pre-PCR
amplification. Libraries were PCR amplified (18 cycles) on a Tetrad (Bio-Rad)
using the NEBNext High-Fidelity 2X PCR Master Mix (NEB) and in-house
(Oxford) single indexing primers91. Individual libraries were normalised using
Qubit, and the size profile was analysed on the 2200 or 4200 TapeStation.
Following normalisation, individual libraries were pooled accordingly. The pooled
library was diluted to ~10 nM for storage. The 10-nM library was denatured and
further diluted prior to loading on the sequencer. Samples were pooled and
multiplexed libraries were sequenced on 5 lanes of an Illumina HiSeq4000 System
to generate 75 basepair (bp) paired-end reads. All samples were assessed for a
number of QC metrics, including Q30 and acceptable Passing Filter (%PF). These
metrics are in agreement with the values recommended by Illumina for this
sequencing machine (HiSeq4000) and read length (75 bp); see https://www.
illumina.com/systems/sequencing-platforms/hiseq-3000-4000/specifications.html
for more details. In particular, the Q30 value was >96% for read 1 and >92% for
read 2 for each of the five sequencing lanes (Recommendation from Illumina:
>80%), whereas the %PF was >77% of the raw cluster data in each of the five lanes.
Moreover, all ChIP-seq samples in our study had a sequencing depth greatly in
excess of the levels recommended for point-source factors in mammalian cells by
the ENCODE Consortium (i.e. minimum of 10 million uniquely mapped reads per
biological replicate), with an average of >25 million read pairs per sample. All
library contruction and sequencing steps were performed by experimenters
unaware of group allocation (blinded).
Genome mapping and bioinformatic analysis of ChIP-Seq data. Sequencing
data were basecalled with the Illumina software bcl2fastq2 and trimmed to remove
any PCR adapters or index primers using Skewer92, with settings:
-f sanger -x AGATCGGAAGAGCACACGTCTGAACTCCAGTCACNNNN
NNNNATCTCGTATGCCGTCTTCTGCTTG -y AGATCGGAAGAGCGTCGTG
TAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATT -m pe -l 25 -r 0.1
Trimmed reads were aligned using Burrows-Wheeler Aligner (BWA-MEM)93
to the Rattus norvegicus (rn6) genome build (Ensembl) using default parameters.
Reads with mapping quality < 20, not properly paired, or with insert size > 1000 bp
were filtered out using Bamtools94. BAM files from individual sequencing lanes
were merged and duplicate reads were removed with PICARD (http://
broadinstitute.github.io/picard). The degree of enrichment for the proteins of
interest was evaluated through the Normalized Strand Cross-correlation (NSC) and
the Relative Strand Cross-correlation (RSC) coefficients, which were calculated for
each ChIP sample; in all cases, NSC and RSC values were > 1.05 and >0.8,
respectively, in agreement with the ENCODE guidelines95. To identify significantly
enriched regions, the peak caller Model based Analysis of ChIP-seq (MACS2) was
used96 with parameters -f BAMPE -g 2.5e9 for GR and MR narrow peaks. Peaks
with a false discovery rate (FDR) lower than 5% were reported and annotated to
their nearest genes (Ensembl release 81) using the Bedtools suite97.
The difference in binding levels between conditions - measured by differences
in read densities - was performed using the R Bioconductor package DiffBind
(version 2.4.8)98,99. DiffBind analysis used MACS2-called MR or GR peaks to
derive a consensus peak set for each transcription factor (MR or GR). Each
consensus peak set contained all peaks that were significantly over input in at least
4 out of 12 samples. The significantly differentially bound sites between sample
groups resulting from this analysis were subjected to motif scanning using FIMO
(MEME suite, version 4.11.2)100 and the position weight matrices for vertebrates
from the JASPAR CORE database101. All the bioinformatic analyses were executed
using in-house scripts written in the Python and R programming languages. The
pipeline of the bioinformatics analysis of our ChIP-Seq data is depicted in
Supplementary Fig. 11. Due to the nature of the bioinformatic analysis blinding
was not possible at this stage.
RNA-seq sample preparation, library construction, sequencing, mapping and
data analysis. RNA sample preparation—RNA was extracted from nine inde-
pendent biological samples per group (BLAM, FS30, FS60, FS120, FS180, FS360
and BLPM) using TRI Reagent® (Sigma, Poole) following manufacturers guidelines.
Each biological sample comprised RNA from hippocampi of one rat. Purified RNA
was treated with DNase I (Qiagen, Germany) and incubated for 10 min at room
temperature. DNase was inactivated by the addition of EDTA (Final conc. 5 mM)
for 10 min at 70°C and RNA was purified over MinElute spin column as per
manufacturer’s instructions (Qiagen, Germany). Three biological samples were
randomly selected from the FS60 and FS120 groups to send for initial sequencing
to confirm the possibility of conducting Ribo-Zero RNA-Seq. Following the success
of this initial test, a further three randomly chosen samples from these groups
(FS60 & FS120), along with five randomly selected samples from each of the other
condition (BLAM, FS30, FS180, FS360 and BLPM) were subjected to RNA-seq.
RNA-seq library construction and sequencing—RNA was quantified using
RiboGreen (Invitrogen) on the FLUOstar OPTIMA plate reader (BMG Labtech)
and the size profile and integrity analysed on the 2200 or 4200 TapeStation
(Agilent, RNA ScreenTape). RIN (RNA integrity number) estimates for all samples
were between 7.4 and 8.5. Input material was normalised to 1 μg prior to library
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preparation. Total RNA was depleted of ribosomal RNA using Ribo-Zero rRNA
Removal Kit (Epicentre/Illumina, Human/Mouse/Rat) following manufacturer’s
instructions. Library preparation was completed using TruSeq Stranded Total RNA
kit (Illumina) following manufacturer’s instructions. Libraries were amplified (15
cycles) on a Tetrad (Bio-Rad) using in-house unique dual indexing primers91.
Individual libraries were normalised using Qubit, and the size profile was analysed
on the 2200 or 4200 TapeStation. Individual libraries were normalised and pooled
together accordingly. The pooled library was diluted to ~10 nM for storage. The 10
nM library was denatured and further diluted prior to loading on the sequencer.
Paired-end sequencing was performed using a HiSeq4000 75 bp platform
(Illumina, HiSeq 3000/4000 PE Cluster Kit and 150 cycle SBS Kit), generating a raw
read count of >45 million reads per sample. All library construction and
sequencing steps were performed by experimenters unaware of group allocation
(blinded).
Genome mapping and bioinformatic analysis of RNA-Seq data. Quality control
analysis was performed on data generated from individual samples as per ChIP (see
above). RNA-Seq read pairs were aligned to Rattus norvegicus reference genome,
Rn6, using a splice-aware aligner, Hisat2 version-2.0.4102. Gene annotation files
were downloaded in GTF format from Ensembl, release 81103. GTF files with
intron coordinates were prepared by subtracting annotated exon features from full-
length transcripts using subtractBed implemented in Bedtools suite v2.26.0. Read
fragments mapping to annotated exon features, or intron features were separately
quantified to obtain exon, or intron count tables, respectively. All reads were
counted with featureCounts104, part of subread-v1.5.0105, using the specified
parameters (“-M” “-O” “—fraction” “-p”). Values for duplication rates and median
3′ bias were estimated using MarkDuplicates.jar, and CollectRnaSeqMetrics.jar
implemented in Picard tools v1.92 (https://broadinstitute.github.io/picard/),
respectively. Normalized read counts and count based metrics were obtained using
in-house R scripts106, R core tools, v 3.1.0.
Differentially expressed genes were identified for each comparison using edgeR
v3.20.4107,108, R core tools, v3.4.2. Each comparison was analyzed separately using
subsets of the exon and intron count tables. First, the count tables were selected to
samples of interest and expressed genes, keeping genes with greater than 10 reads
in each biological replicate in a group. Then, count table subsets were normalized
and data were fit using generalized linear models as implemented in edgeR.
Normalized fitted expression values were tested for differential expression between
groups using likelihood ratio tests, and finally corrected for multiple comparisons
using Benjamini-Hochberg correction109. One biological replicate from the BLAM
group, RN067, showed a different gene expression profile as compared to other
samples in the experiment. We excluded this potential outlier from all downstream
analysis as this sample consistently separated from the data and especially the
BLAM group in hierarchical clustering as well as principal component analysis
(PCA). The pipeline of the bioinformatics analysis of our RNA-Seq data is shown
in Supplementary Fig. 12. Due to the nature of the bioinformatic analysis blinding
was not possible at this stage.
Pathway analysis. GO pathway analysis—Gene Ontology (GO) pathway analysis
was performed using PANTHER (http://geneontology.org/). RNA-expressing gene
sets with associated MR-only binding (n= 366, Fig. 6a), MR-and-GR binding (536
genes, Fig. 6b) or GR-only binding (n= 28 genes) were uploaded individually and
pathway analysis performed against Rattus norvegicus (all genes in database). Given
the low number of RNA-expressing GR-only genes, this analysis did not result in
any significant pathway associations. Unmapped genes were manually checked
and, where possible, gene IDs were replaced with UniProt IDs to ensure inclusion.
Genes which remained unmapped (27 for RNA with MR-only binding; 40 for RNA
with MR-and-GR binding) were generally non-coding RNAs and subsequently
excluded from pathway analysis.
IPA analysis—Ingenuity Pathway Analysis (IPA; Qiagen) software was used to
interpret data from ChIP-seq and RNA-seq experiments. A core analysis was
performed on each dataset by IPA which identified canonical pathways, upstream
regulators, diseases and functions, and networks predicted to be associated with
genes present in the dataset. The settings for all core analyses were as follows: the
reference set of genes was taken from the Ingenuity Knowledge base, interaction
networks were considered, all node types and data sources were included,
experimentally observed predictions were considered, all species were considered,
all tissues and cell lines were considered, and all mutations were considered. A
ChIP-seq dataset comprising all genes annotated to an MR or GR peak included in
DiffBind analysis was uploaded to IPA. For each gene, the fold-change in receptor
binding (vs BLAM), p value and false discovery rate (FDR) was included. In
instances where multiple peaks of the same category were annotated to a single
gene, the largest fold-change value was included in the dataset. In instances where a
peak was annotated to multiple possible genes, all gene options were included in
IPA. A total of 1996 genes were included in the dataset, with IPA mapping 1495
gene IDs and 501 gene IDs left unmapped. 1303 genes with MR binding and 740
genes with GR binding were analysed. Differentially bound genes at FDR ≤ 0.1
were included in the analysis. An FDR cut-off of 1.0 was also used to include
constantly (CON) bound genes.
Core Analysis identified canonical pathways predicted to be influenced by the
genes in the datasets based on the directional changes in receptor binding.
Upstream regulators of the genes in the reference datasets were also predicted by
interactions by correlating literature-reported effects with genes that had changes
in MR/GR binding. Core analysis also identified diseases and functions predicted to
be influenced by genes in the reference datasets. A directional change was also
predicted on cellular processes and biological functions by correlating observed
expression with reported experimental gene effects. Networks were predicted
involving non-directional gene interactions.
An ‘overlap p value’ was calculated using a Right-Tailed Fisher’s Exact Test and
reflects the likelihood that the association or overlap between the set of significant
molecules from the datasets and a given pathway/interaction/network is due to
random chance. A smaller p value indicates a lesser likelihood that the association
is random. The p value does not consider the directional effect of one molecule on
another, or the direction of change of molecules in the dataset.
A ‘Z-score’ was applied in some analysis types and provided predictions about
upstream or downstream processes, considering the directional effect of one
molecule on another molecule or on a process, and the direction of change of
molecules in the dataset. A Z-score will only have an associated predicted
activation state if the Z-score is above 2 or below -2.
Validation and other (RFX) experiments. ChIP-qPCR—Four biologically inde-
pendent replicates were used per condition for the validation studies described
previously (see Animals and Stress procedures), each replicate consisting of the
dissected hippocampi from two animals. Chromatin extraction, input preparation
and MR/GR ChIPs were performed as described for the ChIP-seq study. Due to
discontinuation of all Santa Cruz polyclonal antibodies, validation studies were
performed using anti-MR ab64457 or ab97834 (Abcam, UK) and anti-GR 24050-1-
AP (Proteintech, UK). This further enhances the validity of our findings in
accordance with ENCODE guidelines95. These replacement antibodies were
checked for target specificity by western blotting (Supplementary Fig. 8a–c). Fur-
thermore, the validation experiments also included IgG ChIPs using recommended
IgG isotype control antibodies from the new suppliers (ab171870 (Abcam) and
30000-0-AP (Proteintech)) to determine the non-specific binding (Supplementary
Fig. 8e–h).
In a separate experiment, ChIP was conducted for RFX3 binding on
hippocampal chromatin obtained from rats killed under BLAM conditions or at
different times after FS. The RFX3 ChIP was conducted as described for the MR
and GR ChIPs using a rabbit polyclonal anti-RFX3 antibody (14784-1-AP,
Proteintech; western blot validation in Supplementary Fig. 8d). DNA from input
and ChIP samples was quantified using a Qubit 2.0 fluorometer (Invitrogen, UK).
All samples were diluted to a standardized concentration with nuclease-free water
and analysed using Taqman primers and probes listed in Supplementary Table 2 by
qPCR against a standard curve generated from serial dilutions of rat brain genomic
DNA (MPBiomedicals, UK). Enrichment of genome binding was expressed as
quantity of DNA in ChIP samples (Bound) divided by quantity of DNA in input
samples (Input).
RNA–RT-qPCR—RNA was extracted from 8 biologically independent samples
per group (see above). Each sample comprised RNA from the hippocampi of one
rat. Total RNA (1000 ng) was reverse-transcribed into cDNA using the QuaniTect
Reverse Transcription Kit (Qiagen, UK) as per manufacturer’s instructions (15 min
at 42°C; 5 min at 95°C, BioRad T1000 thermocycler). cDNA was diluted 4-fold and
subjected to qPCR analysis using the Taqman primers and probes included in
Supplementary Table 2. Results were normalised to expression of
two housekeeping genes (Beta-actin (Actb), hypoxanthine
phosphoribosyltransferase 1 (Hprt1) and/or tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein, zeta (Ywhaz)) and expressed as fold-change
over BLAM levels.
hfNPC tissue collection and culture. Human fetal cortex tissue suspended in
phosphate-buffered saline (PBS) was obtained from the SWIFT human foetal
tissue bank at Cardiff University (Cardiff, UK) through medical terminations of
pregnancy with full donor consent and with ethical approval of the project from
the local research ethics committee (SWIFT-RTB 46). PBS was removed and
tissue lysed with Accutase® for 20 min at 37°C to break down into single cells.
Single cells were counted using a hemocytometer and seeded at 2 × 105/ml in
proliferation media containing high-glucose Dulbecco’s Modified Eagle Medium
(DMEM):F12 (3:1; Invitrogen), 1% penicillin/streptomycin (Sigma), 1% Gluta-
Max (Invitrogen) and supplemented with 2% B-27 serum-free supplement
(ThermoFisher), 20 ng/ml fibroblast growth factor (FGF-2), 20 ng/ml epidermal
growth factor (EGF) and 5 µg/ml heparin, and grown in a humidified incubator
at 37°C in 5% CO2. Cells were fed with half the volume taken out and replaced
with fresh medium every 4 days until they had grown into neurospheres of ~1
mm in diameter. Neurospheres were passaged, returned to proliferation media
and incubated as before (37°C, 5% CO2) with regular feeding every 4 days and
passaging every 12–16 days from here on. Some cells were incubated with the
thymidine analog EDU (10 μM) for 24 h to visualize proliferating cells. After
fixation and permeabilization, EDU detection was conducted using the Click-iT
EDU imaging kit (Invitrogen, C10337). Immunocytochemistry was performed as
described below.
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Differentiation of neurospheres. Chamber slides were coated with poly-D-lysine
(0.1 mg/ml, Sigma) for 24 h at 4°C, washed thrice with MilliQ water and air dried.
100 µl of laminin solution (0.01 mg/ml laminin, Sigma, in differentiation media,
pre-warmed) was added, incubated at 37°C for 1 h before replacement with 100 µl
differentiation media (pre-warmed, see below for composition). 2-4 neurospheres
were seeded into each well and slides incubated at 37 °C for 1 h. An additional 200
µl differentiation media was added to each well after the hour incubation and the
cells left to grow in a 37 °C incubator with 5% CO2 for 7 days. Every 2–3 days, cells
were fed by removing half the volume out of the wells and replacing with fresh
medium. During the differentiation process, cells were transferred to one of the
differentiation conditions outlined below. All media were made up in a 3:1 ratio of
DMEM:F12 and a volume of 100% ethanol was added to equalize the concentration
of solvent in all experimental conditions (final ethanol concentration 0.44%). The
composition of the differentiation media was:
● Control N2 (N2): 1% N2 supplement 100x (ThermoFisher) containing
0.02 µM progesterone, 5 nM forskolin, 1 mM bovine serum albumin (BSA),
3.68 µM N-acetyl-cysteine (NAC), 1% penicillin/streptomycin (Pen/Strep),
1% Glutamax (Invitrogen).
● No steroid N2 (N.S.): 10 mM ITS-G (ThermoFisher), 0.1 mM putrescine
dihydrochloride, 5 nM forskolin, 1 mM BSA, 3.68 µM NAC, 1% Pen/Strep,
1% Glutamax.
● Homemade N2 (Prog): as N.S. with the addition of 0.02 µM progesterone
(Sigma).
● Corticosterone replacement (Cort): as N.S. with the addition of 0.1 µM
corticosterone (Sigma).
● DOC replacement (DOC): as N.S. with the addition of 0.01 µM
deoxycorticosterone acetate (Sigma).
Fixation and immunocytochemistry of proliferating cells and differentiated
neurospheres. As described above, proliferating cells were incubated with EDU
before fixation and permeabilization and further processing for
immunocytochemistry.
After 7 days of differentiation, cells were washed in PBS + MgCl2 + CaCl2 and
fixed in 4% paraformaldehyde (PFA)/PBS (20min at room temperature (RT)). Cells
were washed and permeabilized with 400 µl ice-cold methanol (20min at −20°C).
Next, cells were washed in PBS and incubated in 200 µl 10% normal goat serum
(NGS)/PBS (2 h at RT), then incubated with primary antibodies in 10% NGS in PBS
(4°C, overnight).
The primary antibodies used were Tuj1 (1:500, mouse; neuronal marker,
Cat.801202, BioLegend), adenylate cyclase type-3 (AC3, 1:400, rabbit; cilium
marker, PA535382, ThermoFisher), nestin (1:200, mouse; Neural stem cell marker;
4D11, Novus Biologicals) and MR (1:150, rabbit; Ab64457, Abcam). After
incubation, the cells were washed (x3, PBS) and then stained with the secondary
antibodies Alexa 568 (A11004, Fisher Scientific) and Alexa 488 (A11008, Fisher
Scientific) (1:500 in 10% NGS/PBS, (1.5 h at RT). Cells were subsequently washed
(x3, PBS) and their nuclei stained (20 min, RT, 50 µg/ml Hoechst/PBS). Next, cells
were washed (1×, PBS), mounted and coverslipped using Vectashield antifade
mounting media (H-1000-10) and stored in the dark at 4°C until imaging. Cells
were analysed using a Leica DMRB fluorescence microscope with an Retiga R6
camera and images taken using Ocular software at either ×10 or ×40 magnification
to view primary cilia staining through AC3, or neuronal staining through Tuj1,
respectively. Images were analyzed using FIJI (Image J, NIH) software to quantify
the number of cilia per field, or the percentage of Tuj1-positive neurons over
nuclei. Experimenters performing image analysis were blinded to group allocation
of samples.
Western Blot validation of MR, GR and RFX3 antibodies. Hippocampi were
dissected from the brains of male Wistar rats, snap-frozen in liquid nitrogen, and
stored at −80 °C. Briefly, frozen tissue was homogenized in 500 μl of cold radio-
immunoassay precipitation (RIPA) buffer (Thermo Scientific, 89900) with protease
and phosphatase inhibitors (PhosSTOP phosphatase inhibitor mixture tablets, one
per 10 ml, Roche 04906837001; 1× complete ULTRA protease inhibitor cocktail,
Roche 000000006538282001; 2 mM 4-(2-aminoethyl) benzenesulfonyl fluoride
hydrochloride (AEBSF); 1 mM sodium orthovanadate (Na3VO4); 0.1 mM phe-
nylmethanesulfonyl fluoride (PMSF)) using a mechanical homogenizer and then
centrifuged at 20,000 × g at 4°C for 15 min to isolate the soluble proteins. The
whole-cell lysate was mixed with a 4x Bolt LDS sample buffer (Invitrogen, B0007),
incubated at 95°C for 10 minutes and loaded onto Bolt™ 4-12% Bis-Tris plus gels
(Invitrogen, NW04122BOX) along with PageRuler plus prestained protein ladder
(26619, Thermo Scientific) as protein molecular weight indicator. Proteins were
separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) for 20 min at 200 V and transferred to a PVDF membrane (03010040001,
Roche). Membrane blots were blocked with either 5% (w/v) Amersham ECL prime
blocking reagent (RPN418, GE Healthcare, for GR and MR ab97834) or 1.5% or 5%
dried milk (for MR ab64457 and RFX3 14784-1-AP, respectively) in Pierce tris-
buffered saline Tween 20 buffer (TBST, 28360, Thermo Scientific) overnight at 4°C.
Blots were then probed with either anti-GR (24050-1-AP, Proteintech at 1:15,000),
anti-MR (ab64457 and ab97834, rabbit polyclonal; Abcam; 1 μg/ml) or anti-RFX3
(14784-1-AP, rabbit polyclonal, Proteintech; 1:1000) antibodies diluted in blocking
solution for 1.5 h at room temperature and then washed five times with TBST. For
peptide blocking, ab64457 was preincubated with 8× excess blocking peptide
ab74464 overnight at 4°C before being applied to blot. No blocking peptide was
available for ab97834. Membrane blots were incubated with horseradish peroxidase
(HRP)-conjugated secondary antibody (goat anti-rabbit IgG (H+L), #SA00001-2,
Proteintech; 1:50,000 in 5% blocking solution) for 1 h at RT and washed five times
with TBST. Finally, peroxidase activity was revealed using an Amersham ECL
(Enhanced Chemiluminescence) Select Detection Reagent (GE Healthcare,
RPN2235) for GR and MR or the Novex™ ECL Chemiluminescent Substrate
Reagent Kit (Thermofisher, WP20005) for RFX3 and visualized with a G:Box
Chemi XT4 imaging system (Syngene).
Statistical Analysis of correlation data, corticosterone data, and ChIP and
RNA validation data. The statistical and graphical package GraphPad Prism 8 was
used to generate figures and perform Spearman rank correlation and other sta-
tistical analyses (GraphPad Software, San Diego, CA, USA). The independent
biological sample sizes (n-values) are indicated in the legends to the figures. The
plasma corticosterone, ChIP-qPCR and RNA RT-qPCR data were analyzed with
One or Two-way ANOVA followed by the post-hoc Dunnett’s (for one-way) or
Bonferroni (for two-way) multiple comparison test, as appropriate. Quantification
of cilia and neurons, and percentage of neurons over nuclei were statistically
analysed using One-way ANOVA and post-hoc Dunnett’s test, comparing the mean
of each group to the control ‘N2’ or vehicle group, as appropriate. No statistical
analysis was conducted on observations from cells differentiated in N.S. (i.e. the no-
steroid condition) as the data did not fit the assumptions of ANOVA (zero cells to
count). Testing was always two-sided, as appropriate. P < 0.05 was considered
statistically significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data generated in this publication have been deposited in NCBI’s Gene Expression
Omnibus (GEO)90 and are accessible through GEO Series accession number GSE126706.
Source data on the ChIP-qPCR, RNA RT-qPCR, plasma corticosterone, Tuj1-positive
cell numbers and cilia numbers generated in this study are provided in the Source Data
File. Source data are provided with this paper.
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